No definition available.
Left ventricular outflow tract obstruction (LVOTO), broad definition
Q17_LVOTO_BROAD
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
523 |
4. Check minimum number of eventsNone |
523 |
5. Include endpoints |
4031 |
6. Filter based on genotype QC (FinnGen only) |
4031 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF12
Left ventricular outflow tract obstruction (LVOTO), broad definition
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 26025 | 8905 | 16988 |
| Only index persons | 22742 | 7864 | 14878 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.40 | 0.26 | 0.47 |
| Only index persons | 0.47 | 0.29 | 0.57 |
| Median age at first event (years) | |||
| Whole population | 48.76 | 48.28 | 48.99 |
| Only index persons | 49.44 | 49.25 | 49.53 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4031 | 1491 | 2540 |
| Unadjusted period prevalence (%) | 0.89 | 0.51 | 1.12 |
| Median age at first event (years) | 51.65 | 51.08 | 51.99 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3654
- Matched controls
- 36525
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
173.2
323.0
2297
352
Q25.1
ICD-10 Finland
Coarctation of aorta
+∞
323.0
313
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
20.2
323.0
921
599
B01AA03
ATC
warfarin; systemic
11.4
323.0
1761
2753
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
77.7
323.0
808
133
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
8.8
323.0
1991
4364
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
332.5
323.0
678
25
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
13.1
323.0
1070
1117
C07AB07
ATC
bisoprolol; oral
4.0
323.0
2237
10305
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
79.4
323.0
946
160
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
9.2
323.0
1697
3148
I35.0
ICD-10 Finland
Aortic (valve) stenosis
64.3
323.0
1516
398
Q23.11
ICD-10 Finland
Bicuspid aortic valve
146.1
323.0
679
57
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
6.3
323.0
1613
4098
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
25.1
323.0
708
346
K83
ICPC
Heart valve disease NOS
71.0
318.3
365
57
WX872
NOMESCO Finland
Intensive care
9.3
294.7
660
847
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
6.7
292.8
829
1523
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.7
269.7
1094
3038
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
255.0
2095
10483
AB1
HP
AVR mechanical
232.2
233.7
239
11
C03CA01
ATC
furosemide; systemic
3.9
230.3
1165
3894
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
32.5
222.5
297
99
I48
ICD-10 Finland
Atrial fibrillation and flutter
4.0
214.5
1029
3249
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
23.8
210.0
306
140
FCA60
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis
119.2
207.8
224
20
B01AB05
ATC
enoxaparin; parenteral
3.2
200.3
1459
6340
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
10.5
190.7
390
410
AN1
HP
Coronary angiography
4.7
186.5
718
1809
201
Kela drug reimbursment
Chronic cardiac insufficiency
8.9
180.1
407
510
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
14.3
172.9
303
229
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.6
169.9
541
1097
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
155.3
826
2747
XF640
NOMESCO Finland
NA
11.2
153.9
303
293
PD5BD
NOMESCO Finland
Extensive CT of aorta
12.8
145.8
268
224
I50.9
ICD-10 Finland
Heart failure, unspecified
4.7
145.3
544
1307
XF402
NOMESCO Finland
ECG with work load test
3.8
139.7
667
2010
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
15.1
132.8
227
160
81
HP
Angiography of the heart and coronary arteries
6.5
132.3
367
616
TFP20
NOMESCO Finland
Cardiodefibrillation
4.6
130.9
494
1189
XF404
NOMESCO Finland
Ambulatory ECG
4.0
128.8
571
1603
K84
ICPC
Heart disease other
10.5
127.1
258
263
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.0
126.1
871
3444
C01AA05
ATC
digoxin; systemic
6.1
122.4
355
630
C09AA05
ATC
ramipril; oral
2.7
122.3
1048
4733
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
5.5
115.4
365
719
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
12.7
114.9
211
175
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
5.5
114.8
367
732
K78
ICPC
Atrial fibrillation/flutter
5.1
113.4
388
836
C03DA01
ATC
spironolactone; oral
3.8
112.5
531
1562
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
112.0
1264
6577
I35.9
ICD-10 Finland
Aortic valve disorder, unspecified
55.1
111.5
133
25
XFE00
NOMESCO Finland
Epicardial ultrasonography
9.3
110.7
240
275
21
HP
Aortic Valve Replacement (AVR)
559.4
110.4
109
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.9
110.0
807
3279
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.9
107.7
384
863
FCA50
NOMESCO Finland
Resection and reconstruction of ascending aorta using tube graft
43.3
107.5
134
32
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
6.2
106.7
305
529
C07AB02
ATC
metoprolol; systemic
2.8
104.1
769
3125
I34.1
ICD-10 Finland
Mitral (valve) prolapse
7.8
103.5
249
338
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
25.5
97.5
138
56
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
47.2
97.2
119
26
74719
ICD-8 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta
479.8
94.8
94
*
I35.8
ICD-10 Finland
Other aortic valve disorders
62.9
94.3
110
18
Q23.0
ICD-10 Finland
Congenital stenosis of aortic valve
192.8
90.7
94
5
K99
ICPC
Cardiovascular disease other
8.5
88.5
201
248
AJ1
HP
Reconstruction of the aortic base, eg composite graft, incl. valve saving operation
84.8
88.5
99
12
61
HP
Catheterization and pressure measurement of the left side of the heart
12.3
88.3
164
139
C01BD01
ATC
amiodarone; systemic
6.5
86.9
238
388
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
85.6
533
1914
ZXD05
NOMESCO Finland
Urgent procedure
2.1
82.6
1210
6892
J01CA04
ATC
amoxicillin; systemic
2.2
79.8
3015
24837
PC1BD
NOMESCO Finland
Extensive CT of thoracic aorta
23.0
79.6
116
52
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
9.8
77.3
161
171
I44.2
ICD-10 Finland
Atrioventricular block, complete
8.7
76.4
171
206
7471A
ICD-9 Finland
Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]
+∞
76.3
73
*
I50.1
ICD-10 Finland
Left ventricular failure
5.4
76.1
242
475
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
6.3
75.9
212
354
I50.0
ICD-10 Finland
Congestive heart failure
4.9
75.9
263
568
FC1AC
NOMESCO Finland
Angiography of thoracal aortta
29.9
75.5
102
35
62
HP
Catheterization and pressure measurement of the right side of the heart
43.3
71.7
89
21
207
Kela drug reimbursment
Chronic arrhythmias
2.8
70.3
510
2006
211
HP
AVR mechanical
701.2
70.3
69
*
Z2221
NOMESCO Finland
Medical doctor
2.1
70.0
1060
6030
R4110
NOMESCO Finland
Physiotherapy
2.1
69.9
1073
6140
AB2
HP
AVR bio, stent
42.3
69.7
87
21
Q23.10
ICD-10 Finland
Congenital insufficiency of aortic valve
148.9
69.2
73
5
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
5.5
68.6
213
406
I10
ICD-10 Finland
Essential (primary) hypertension
1.8
66.8
1911
13671
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
66.3
838
4397
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
14.7
64.5
110
77
WX892
NOMESCO Finland
Monitored bed care
3.1
64.4
387
1341
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
63.8
1580
10699
R06.0
ICD-10 Finland
Dyspnoea
2.1
62.2
862
4687
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
4.8
61.8
215
465
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
60.5
993
5772
205
Kela drug reimbursment
Chronic hypertension
2.0
60.1
887
4941
I97.0
ICD-10 Finland
Postcardiotomy syndrome
26.0
60.0
84
33
ZXD10
NOMESCO Finland
Scheduled procedure
1.8
59.9
1410
9327
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
31.4
57.9
77
25
C10AA05
ATC
atorvastatin; oral
1.8
57.7
1335
8751
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.0
57.3
362
1293
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.2
57.3
186
373
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
35.4
56.5
73
21
C07AA07
ATC
sotalol; systemic
5.3
55.5
178
352
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
54.7
1051
6433
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
9.3
54.6
116
128
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
3.2
54.2
307
1016
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.2
54.0
300
980
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
4.4
53.6
204
483
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
20.2
53.6
81
41
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.0
53.4
223
577
N02BE01
ATC
paracetamol; systemic, rectal
1.9
51.3
2981
25606
WX402
NOMESCO Finland
General anaesthesia
2.1
51.0
715
3863
PD5BG
NOMESCO Finland
MRI examination of thoracal and abdominal aortta with high intensity magnet
55.4
50.7
60
11
31
HP
Congenital heart failure surgery
59.9
50.5
59
10
AA1AD
NOMESCO Finland
CT of head and brain
2.0
50.2
800
4544
I33.9
ICD-10 Finland
Acute endocarditis, unspecified
37.7
49.5
63
17
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
18.3
49.3
77
43
Z95.3
ICD-10 Finland
Presence of xenogenic heart valve
26.6
49.1
68
26
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
17.3
49.0
78
46
I71.00
ICD-10 Finland
Dissecting aneurysm of aorta (ruptured) [any part]
18.4
48.9
76
42
I35
ICD-10 Finland
Nonrheumatic aortic valve disorders
107.5
48.9
53
5
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
48.7
1065
6757
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
32.5
48.6
64
20
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
6.9
48.4
124
184
FKB10
NOMESCO Finland
Annuloplasty of mitral valve for insufficiency using ring
9.5
48.2
101
109
Q24.4
ICD-10 Finland
Congenital subaortic stenosis
+∞
48.0
46
*
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
13.9
47.8
83
61
AP1
HP
Catheterization of the left side of the heart
7.4
46.5
114
159
ZXE00
NOMESCO Finland
One hour or less
1.7
46.4
1380
9601
Q25.3
ICD-10 Finland
Stenosis of aorta
463.4
46.4
46
*
PD5AD
NOMESCO Finland
CT of aorta
6.9
46.1
118
175
5273
FHL
Repair with flap prosthesis or graft
124.1
45.8
49
*
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
11.7
45.4
85
74
FC1BC
NOMESCO Finland
Extensive angiography of thoracal aortta
33.3
45.1
59
18
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
14.9
45.1
76
52
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
25.6
45.0
63
25
AJ2
HP
Reconstruction of the ascending aorta
45.6
44.2
54
12
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.9
43.5
147
308
FCA75
NOMESCO Finland
Valve-sparing repair of aortic root (David, Yacoub)
95.2
42.8
47
5
Q25.40
ICD-10 Finland
Aortic hypoplasia
+∞
42.8
41
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
42.7
782
4638
FM2CE
NOMESCO Finland
NA
7.4
41.9
102
141
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
7.8
41.8
98
128
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
3.0
41.8
255
886
N02AX02
ATC
tramadol; systemic, rectal
1.6
41.7
1473
10658
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
25.6
41.5
58
23
FCA70
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft
22.6
41.4
60
27
C08CA01
ATC
amlodipine; oral
1.7
41.3
1133
7629
R50.9
ICD-10 Finland
Fever, unspecified
2.1
41.0
527
2722
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.3
40.6
398
1819
C09AA02
ATC
enalapril; systemic
1.9
40.1
630
3526
C10AA01
ATC
simvastatin; oral
1.6
39.8
1289
9077
WW502
NOMESCO Finland
Autotransfusion
11.8
39.7
74
64
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
13.5
39.4
69
52
XF600
NOMESCO Finland
Bloodpressure measurement
2.7
39.1
286
1114
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.1
39.1
515
2685
R04.0
ICD-10 Finland
Epistaxis
2.8
39.0
270
1016
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
22.7
38.8
56
25
4241A
ICD-9 Finland
Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA VALVULAE AORTAE (NON RHEUMATICA)]
381.2
38.1
38
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.1
37.8
215
712
7463A
ICD-9 Finland
Other congenital anomalies of heart, Congenital stenosis of aortic valve[STENOSIS VALVULAE AORTAE CONGENITA]
+∞
37.6
36
*
Q21.10
ICD-10 Finland
Persistent ostium secundum
9.9
37.4
76
78
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
37.4
635
3646
Z50.0
ICD-10 Finland
Cardiac rehabilitation
7.3
37.2
91
127
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
17.1
37.1
59
35
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
36.5
752
4607
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
36.5
598
3386
WZC30
NOMESCO Finland
Teaching
2.0
36.3
511
2732
I42.0
ICD-10 Finland
Dilated cardiomyopathy
3.9
36.1
153
401
I47.1
ICD-10 Finland
Supraventricular tachycardia
3.3
35.9
194
619
Q25.0
ICD-10 Finland
Patent ductus arteriosus
17.0
35.8
57
34
PD5DG
NOMESCO Finland
Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
31.7
35.7
47
15
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
22.5
35.2
51
23
74673
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae aortae
181.7
34.8
36
*
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.7
34.8
260
1024
TK800
NOMESCO Finland
Hemodialysis
4.2
34.2
134
327
Z95.4
ICD-10 Finland
Presence of other heart-valve replacement
23.1
33.5
48
21
5253
FHL
Cardiac lung machine
13.4
33.1
58
44
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
32.7
1211
8711
I47.2
ICD-10 Finland
Ventricular tachycardia
4.6
32.6
116
258
I49.5
ICD-10 Finland
Sick sinus syndrome
4.5
32.5
119
272
C01DA14
ATC
isosorbide mononitrate; oral
2.2
32.1
346
1646
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.6
31.3
241
966
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
8.0
31.0
71
90
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
30.3
347
1693
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
30.2
886
5979
127
Kela drug reimbursment
Transplant complication
4.6
30.2
108
242
O99.4
ICD-10 Finland
Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium
21.2
30.0
44
21
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.2
29.8
330
1587
WX870
NOMESCO Finland
Other postsurgical intensive care
13.6
29.5
51
38
Q87.4
ICD-10 Finland
Marfan syndrome
30.3
29.4
39
13
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.7
29.3
206
781
K29
ICPC
Cardiovascular sympt/complt other
3.3
29.3
154
482
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
29.3
480
2703
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.2
29.1
113
274
I71.09
ICD-10 Finland
Aortic dissection [regardless of location]
13.7
29.0
50
37
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
5.8
28.9
83
145
PD5CD
NOMESCO Finland
Very extensive CT angiography of aorta
10.7
28.9
56
53
L04AA06
ATC
mycophenolic acid; systemic
4.3
28.8
110
263
K22
ICPC
Risk factor cardiovascular disease
2.8
28.6
190
698
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
28.5
419
2266
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
3.0
28.3
170
585
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
4.2
28.2
111
273
Z3231
NOMESCO Finland
Registered nurse
1.6
28.2
930
6450
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.0
28.2
172
596
C10AX09
ATC
ezetimibe; oral
2.0
28.1
404
2164
AP2
HP
Catheterization of the right side of the heart
15.5
28.1
46
30
Q20.3
ICD-10 Finland
Discordant ventriculoarterial connection
27.4
28.0
38
14
FXA10
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure
27.4
28.0
38
14
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
4.4
27.9
104
243
I38
ICD-10 Finland
Endocarditis, valve unspecified
20.7
27.8
41
20
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
4.8
27.7
95
204
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
27.7
290
1361
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
27.6
656
4155
C08CA05
ATC
nifedipine; systemic
2.6
27.4
203
796
WX002
NOMESCO Finland
Sedation and analgesia
1.7
27.4
615
3834
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
7.0
27.2
68
99
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
6.1
26.7
74
124
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
26.7
2670
29530
AP3
HP
Catheterization of the right and left side of the heart
16.1
26.7
43
27
XF622
NOMESCO Finland
Measurement of minute volume of heart
11.2
26.5
50
45
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.3
26.3
252
1132
FMC96
NOMESCO Finland
Other operation on aortic valve for insufficiency
+∞
26.1
25
*
R55
ICD-10 Finland
Syncope and collapse
2.1
25.9
320
1610
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.8
25.9
174
644
A02BC02
ATC
pantoprazole; systemic
1.4
25.7
2066
17284
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.8
25.5
110
294
R01.1
ICD-10 Finland
Cardiac murmur, unspecified
4.0
25.5
103
260
ZX120
NOMESCO Finland
Intravenous
2.1
25.4
323
1645
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.9
25.2
409
2287
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
25.1
1236
9348
5513
FHL
Coarctation resection, plastic or bypass
+∞
25.0
24
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.9
24.8
103
267
C07AG02
ATC
carvedilol; oral
2.5
24.7
196
799
R42
ICD-10 Finland
Dizziness and giddiness
1.7
24.6
568
3557
B01AC04
ATC
clopidogrel; oral
1.8
24.5
439
2537
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
6.0
24.4
68
115
J01FF01
ATC
clindamycin; systemic
1.5
24.2
903
6410
FFM10
NOMESCO Finland
Occlusion or excision of atrial appendage externally with a closing device
15.0
24.2
40
27
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.3
24.2
227
1008
C08CA02
ATC
felodipine; oral
2.1
23.6
266
1287
26
HP
Aortic root """"composite graft""""
125.8
23.6
25
*
G45.3
ICD-10 Finland
Amaurosis fugax
4.5
23.5
85
194
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.4
23.4
209
907
A11CC03
ATC
alfacalcidol; systemic
3.7
23.2
105
293
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
3.1
23.2
128
417
C02EA02
ATC
NA
3.3
23.0
118
364
AC4
HP
MVP
9.9
23.0
46
47
GD1LA
NOMESCO Finland
GD
5.3
22.9
71
137
7464A
ICD-9 Finland
Other congenital anomalies of heart, Congenital insufficiency of aortic valve
+∞
22.9
22
*
FMC20
NOMESCO Finland
Suture of leaflet of aortic valve
+∞
22.9
22
*
SPAT1263
SPAT
Sampling
1.5
22.9
1289
9972
20199
ICD-8 Finland
Hodgkin's disease
65.4
22.8
26
*
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
5.5
22.7
68
126
C09CA01
ATC
losartan; oral
1.6
22.7
743
5099
Q23.4
ICD-10 Finland
Hypoplastic left heart syndrome
83.9
22.7
25
*
I71.1
ICD-10 Finland
Thoracic aortic aneurysm, ruptured
40.3
22.6
28
7
Z94.1
ICD-10 Finland
Heart transplant status
13.7
22.2
38
28
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
22.2
260
1280
TFP34
NOMESCO Finland
Electrophysiological investigation
2.8
22.1
144
523
GE1BE
NOMESCO Finland
Mediastinal ultrasound examinaiton through oesophagus
24.0
22.1
31
13
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
21.9
1082
8134
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
5.2
21.9
68
132
Z3226
NOMESCO Finland
Physiotherapist
1.6
21.6
606
3997
WX882
NOMESCO Finland
High dependency care
2.8
21.5
143
525
Z94.0
ICD-10 Finland
Kidney transplant status
4.6
21.4
75
166
I48.2
ICD-10 Finland
Chronic atrial fibrillation
3.9
21.4
88
227
I44.1
ICD-10 Finland
Atrioventricular block, second degree
4.6
21.3
75
167
FDJ42
NOMESCO Finland
Percutaneous transluminal angioplasty of thoracic aorta in coarctation
+∞
20.8
20
*
7463D
ICD-9 Finland
Other congenital anomalies of heart, Congenital stenosis of aortic valve[BIKUSPINEN AORTALÄPPÄ]
+∞
20.8
20
*
A12BA01
ATC
potassium chloride; oral
3.5
20.7
99
290
421
HP
Reconstruction of the aortic base, e.g., composite graft
211.1
20.6
21
*
FDJ00
NOMESCO Finland
End to end reconstruction of aorta for coarctation
211.1
20.6
21
*
M01AH05
ATC
etoricoxib; oral
0.7
20.4
1424
17204
AS4
HP
Physiological pacemaker insertion DDD (R)
6.4
20.4
54
86
Q25.48
ICD-10 Finland
Other congenital malformations of the aorta
48.3
20.1
24
5
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
5.5
20.0
59
108
AA1
HP
Conventional CABG
4.1
19.9
78
193
FMD40
NOMESCO Finland
Replacement of aortic root using pulmonary autograft and reimplantation of coronary arteries (Ross)
+∞
19.8
19
*
J01DB01
ATC
cefalexin; oral
1.4
19.6
2792
25269
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.8
19.6
346
1988
Q20.1
ICD-10 Finland
Double outlet right ventricle
105.6
19.6
21
*
74679
ICD-8 Finland
Congenital anomalies of heart, Aliae malformationes valvulae aortae sive ventriculi sinistri
201.0
19.6
20
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
5.0
19.6
63
128
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
2.4
19.3
162
681
WX704
NOMESCO Finland
Intubation
2.0
19.2
249
1275
FXA20
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and circulatory arrest at concurrent surgical procedure
15.6
19.2
31
20
FGC10
NOMESCO Finland
Annuloplasty of tricuspid valve using prosthetic ring
16.8
19.1
30
18
I48.1
ICD-10 Finland
Persistent atrial fibrillation
3.5
19.0
91
268
Q21.0
ICD-10 Finland
Ventricular septal defect
55.3
18.9
22
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
18.8
194
902
SPAT1260
SPAT
Consultation of another employee
1.6
18.8
511
3329
A40.8
ICD-10 Finland
Other streptococcal sepsis
6.4
18.8
49
77
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
18.8
229
1147
H53.1
ICD-10 Finland
Subjective visual disturbances
2.2
18.7
201
954
Z95.9
ICD-10 Finland
Presence of cardiac and vascular implant and graft, unspecified
18.8
18.6
28
15
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
18.8
18.6
28
15
SPAT1325
SPAT
Vaccination
1.5
18.6
908
6769
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
100.5
18.6
20
*
5255
FHL
Deep hypothermia (<20 °) with cardiopulmonary resuscitation
100.5
18.6
20
*
I34.01
ICD-10 Finland
Mitral (valve) regurgitation NOS or of specified cause, except rheumatic
7.9
18.5
42
54
FKC50
NOMESCO Finland
Repair of mitral valve for insufficiency using prosthetic chord
6.6
18.1
46
70
C09CA06
ATC
candesartan; oral
1.5
18.0
637
4428
342
Kela drug reimbursment
Dronedarone
8.4
17.9
39
47
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.1
17.9
204
991
R00.2
ICD-10 Finland
Palpitations
2.1
17.8
215
1071
FN1BB
NOMESCO Finland
Contrast angiography of heart and/or coronary arteries after bypass surgery
5.3
17.8
54
103
N18.8
ICD-10 Finland
Other chronic renal failure
3.1
17.7
101
337
XF620
NOMESCO Finland
Examination of circulation with color method
8.5
17.6
38
45
FDA00
NOMESCO Finland
Aortoplasty and aorto-pulmonary shunt for HLHS
95.5
17.6
19
*
FMB10
NOMESCO Finland
Transannular expansion of aortic ostium
180.8
17.5
18
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
17.5
1226
9751
R07.3
ICD-10 Finland
Other chest pain
1.9
17.5
281
1563
A12AA04
ATC
calcium carbonate; oral
3.8
17.4
74
198
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
4.1
17.4
67
164
C08DB01
ATC
diltiazem; oral
2.8
17.4
115
423
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.1
17.4
96
315
FL1AC
NOMESCO Finland
Left cardioangiography
4.1
17.3
68
170
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.6
17.2
77
215
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
17.2
290
1640
SPAT1097
SPAT
Recording of ECG
1.7
17.1
410
2577
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.2
17.1
185
882
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.0
17.0
69
177
I50
ICD-10 Finland
Heart failure
4.0
17.0
69
177
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.8
17.0
110
400
PD5CM
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet
21.9
16.8
24
11
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.2
16.8
178
840
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
35.2
16.7
21
6
I71.6
ICD-10 Finland
Thoracoabdominal aortic aneurysm, without mention of rupture
15.1
16.6
27
18
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.2
16.6
176
828
TK810
NOMESCO Finland
Hemofiltration
6.1
16.6
45
75
25
HP
Valve and coronary artery bypass surgery
90.4
16.6
18
*
7454B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]
90.4
16.6
18
*
TFC20
NOMESCO Finland
Catheterisation of both sides of heart
16.4
16.5
26
16
4241B
ICD-9 Finland
Other diseases of endocardium, Aortic valve disorders[STENOSIS VALVULAE AORTAE (NON RHEUMATICA)]
170.7
16.5
17
*
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
16.5
380
2365
FCC45
NOMESCO Finland
Percutaneous insertion of stent into descending aorta
27.6
16.5
22
8
K92.1
ICD-10 Finland
Melaena
2.3
16.5
149
651
Q21.19
ICD-10 Finland
Atrial septal defect NOS
10.8
16.4
31
29
C10AA07
ATC
rosuvastatin; oral
1.5
16.2
745
5466
I49.1
ICD-10 Finland
Atrial premature depolarization
2.7
16.1
108
402
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.2
16.0
165
769
Q20.48
ICD-10 Finland
Single ventricle
47.7
16.0
19
*
R31
ICD-10 Finland
Unspecified haematuria
1.8
15.9
279
1596
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.4
15.9
140
606
FXZ00
NOMESCO Finland
Off-pump cardiac operation
8.4
15.7
34
41
FPD10
NOMESCO Finland
Surgical ablation of atrial fibrillation
15.7
15.7
25
16
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.8
15.7
294
1718
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.5
15.7
552
3825
UJF32
NOMESCO Finland
Coloscopy
1.5
15.6
714
5226
FPE96
NOMESCO Finland
Other implantation or replacement of transvenous cardiac pacemaker
9.8
15.6
31
32
FLE96
NOMESCO Finland
Other repair of outlet obstruction of left ventricle
+∞
15.6
15
*
M04AA01
ATC
allopurinol; systemic
1.7
15.6
352
2178
FPD96
NOMESCO Finland
Other operation for atrial fibrillation
22.1
15.5
22
10
4241C
ICD-9 Finland
Other diseases of endocardium, Aortic valve disorders[INSUFFICIENTIA/STENOSIS VALVULAE AORTAE (NON RHEUM)]
160.6
15.5
16
*
C07AB03
ATC
atenolol; systemic
2.3
15.4
145
645
I34.8
ICD-10 Finland
Other nonrheumatic mitral valve disorders
14.8
15.3
25
17
A41.9
ICD-10 Finland
Sepsis, unspecified
2.5
15.3
118
477
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
16.1
15.2
24
15
3A064
NOMESCO Finland
NA
8.3
15.2
33
40
FM1CD
NOMESCO Finland
Very extensive CT of heart
8.3
15.2
33
40
FM1DE
SPAT
NA
10.4
15.2
29
28
C09AA04
ATC
perindopril; oral
2.2
15.2
161
759
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.1
15.2
58
142
C10AA03
ATC
pravastatin; oral
2.0
15.1
191
971
C08DA01
ATC
verapamil; systemic
2.5
15.1
116
467
TFN04
NOMESCO Finland
NA
14.0
15.0
25
18
PA1BD
NOMESCO Finland
Extensive CT of aortic arch and branches
14.0
15.0
25
18
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.4
15.0
131
565
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.1
14.8
46
91
137
Kela drug reimbursment
Uraemia requiring dialysis
4.8
14.8
48
100
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
14.7
326
2004
B03XA02
ATC
darbepoetin alfa; parenteral
3.4
14.7
71
212
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.5
14.7
69
202
PC1AD
NOMESCO Finland
CT of thoracic aorta
25.1
14.7
20
8
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.7
14.6
97
360
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
3.0
14.6
84
283
Q23.9
ICD-10 Finland
Congenital malformation of aortic and mitral valves, unspecified
+∞
14.6
14
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.8
14.6
249
1412
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
2.5
14.6
116
475
C09AA01
ATC
captopril; oral
4.3
14.6
53
124
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
14.5
147
679
FXG00
NOMESCO Finland
Insertion and use of IABP
14.2
14.5
24
17
A41.8
ICD-10 Finland
Other specified sepsis
3.7
14.5
63
173
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
5.8
14.5
40
69
FXA13
NOMESCO Finland
Total cardiopulmonary bypass in deep hypothermia and exclusive cerebral perfusion
150.5
14.5
15
*
FCA96
NOMESCO Finland
Other repair of ascending aorta
150.5
14.5
15
*
A46
ICD-10 Finland
Erysipelas
1.6
14.5
403
2638
J01XX08
ATC
linezolid; systemic
7.3
14.5
34
47
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
4.7
14.4
48
103
AC1
HP
MVR mechanical
19.2
14.2
21
11
23
HP
Mitral valve plasty
22.3
14.2
20
9
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.0
14.2
186
961
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.9
14.1
203
1085
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
14.1
2136
18897
B05DA
ATC
Isotonic solutions
5.3
14.0
42
80
B01AB04
ATC
dalteparin; parenteral
2.2
13.9
140
644
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.8
13.9
58
154
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.2
13.9
73
233
K80
ICPC
Cardiac arrhythmia NOS
1.9
13.9
198
1057
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.4
13.8
49
112
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.8
13.7
90
332
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
14.7
13.5
22
15
FMD96
NOMESCO Finland
Other prosthetic replacement of aortic valve
+∞
13.5
13
*
74659
ICD-8 Finland
Congenital anomalies of heart, Maleformatio valvulae mitralis
+∞
13.5
13
*
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
4.4
13.5
48
110
Z31.5
ICD-10 Finland
Genetic counselling
2.1
13.5
154
752
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.5
13.5
106
433
FM1AT
NOMESCO Finland
Percutaneous implantation of aortic valve endoprosthesis
140.4
13.4
14
*
I71.01
ICD-10 Finland
Aneurysm of the descending aorta
10.1
13.4
26
26
J01MA12
ATC
levofloxacin; systemic
1.5
13.4
529
3746
V03AE02
ATC
sevelamer; oral
5.7
13.3
37
65
Z2446
NOMESCO Finland
Social worker
1.8
13.3
227
1291
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.3
13.2
123
549
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
13.2
721
5439
74699
ICD-8 Finland
Congenital anomalies of heart, Unspecified anomalies of heart
40.2
13.1
16
*
C01BD07
ATC
dronedarone; oral
7.5
13.1
30
40
K77
ICPC
Heart failure
4.0
13.1
51
128
Z01.2
ICD-10 Finland
Dental examination
1.3
13.1
1308
10869
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
13.0
221
1249
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
5.0
13.0
41
83
V03AE01
ATC
polystyrene sulfonate; oral
4.1
13.0
50
124
B05DB
ATC
Hypertonic solutions
6.0
13.0
35
59
R2110
NOMESCO Finland
Giving the first information
1.9
13.0
188
1008
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
4.4
12.9
46
106
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.1
12.9
70
229
74709
ICD-8 Finland
Other congenital anomalies of circulatory system, Patent ductus arteriosus
22.6
12.9
18
8
H02AB06
ATC
prednisolone; systemic
1.3
12.9
1376
11534
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
5.0
12.9
40
80
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
6.6
12.8
32
49
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
12.8
202
1118
FWW96
NOMESCO Finland
Other reoperation on heart or major thoracic vessels
14.1
12.7
21
15
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
5.1
12.7
39
77
FKC20
NOMESCO Finland
Plastic repair of mitral valve leaflet for insufficiency
9.7
12.7
25
26
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
12.7
1455
12314
74663
ICD-8 Finland
Congenital anomalies of heart, Stenosis valvulae pulmonalis
32.1
12.6
16
5
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
12.5
143
700
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
3.5
12.5
58
169
XF409
NOMESCO Finland
Other special ECG
5.9
12.5
34
58
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
8.2
12.5
27
33
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
8.2
12.5
27
33
4242A
ICD-9 Finland
Other diseases of endocardium, Tricuspid valve disorders, specified as nonrheumatic
+∞
12.5
12
*
90492
NOMESCO Finland
NA
+∞
12.5
12
*
TFJ02
NOMESCO Finland
Muscle biopsy of heart
11.0
12.5
23
21
C03AA03
ATC
hydrochlorothiazide; oral
1.8
12.5
220
1263
FMC10
NOMESCO Finland
Reduction of leaflet of aortic valve
130.4
12.4
13
*
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.2
12.4
127
591
1CX08
NOMESCO Finland
NA
7.6
12.4
28
37
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
12.4
103
436
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
2.9
12.4
76
268
FPW96
NOMESCO Finland
Other operation for arhythmia or disturbance of impulse propagation
8.0
12.3
27
34
C08CA13
ATC
lercanidipine; oral
1.6
12.3
330
2138
AJ3
HP
Reconstruction of the aortic arch
37.6
12.2
15
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.3
12.1
59
179
I37.1
ICD-10 Finland
Pulmonary valve insufficiency
15.9
12.1
19
12
-
ICD-10 Finland
NA
2.7
12.0
81
306
RS224
NOMESCO Finland
NA
5.5
11.9
34
62
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
46.8
11.9
14
*
FDF05
NOMESCO Finland
Percutaneous transluminal occlusion of aorto-pulmonary collaterals
46.8
11.9
14
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
3.0
11.8
68
231
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
6.1
11.8
31
51
I25.2
ICD-10 Finland
Old myocardial infarction
1.9
11.8
159
833
I37.0
ICD-10 Finland
Pulmonary valve stenosis
14.7
11.8
19
13
3A422
NOMESCO Finland
NA
14.7
11.8
19
13
742
NOMESCO Finland
NA
8.4
11.8
25
30
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.9
11.7
166
885
C02AC05
ATC
moxonidine; oral
2.1
11.7
125
597
FHB50
NOMESCO Finland
Transatrial closure of VSD using patch
30.1
11.6
15
5
M10.9
ICD-10 Finland
Gout, unspecified
1.8
11.6
183
1012
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.4
11.6
94
390
22
HP
Mitral valve Replacement (MVR)
65.1
11.6
13
*
FBE10
NOMESCO Finland
Expansion or reconstruction of pulmonary artery using patch
22.9
11.6
16
7
AD1
HP
TVP
22.9
11.6
16
7
Q21.9
ICD-10 Finland
Congenital malformation of cardiac septum, unspecified
22.9
11.6
16
7
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
11.6
468
3329
K28
ICPC
Limited function/disability (K)
3.2
11.6
59
186
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
4.6
11.5
39
86
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.7
11.5
217
1274
Z98.8
ICD-10 Finland
Other specified postsurgical states
3.4
11.5
55
165
7468X
ICD-9 Finland
Other congenital anomalies of heart, Other specified anomalies of heart[MUU SYDÄMEN EPÄMUODOSTUMA]
+∞
11.5
11
*
7466A
ICD-9 Finland
Other congenital anomalies of heart, Congenital mitral insufficiency
+∞
11.5
11
*
111
HP
Conventional CABG
5.9
11.5
31
53
PD5DM
NOMESCO Finland
Very extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet
120.3
11.4
12
*
XG410
NOMESCO Finland
Flow-volume spirometry
2.1
11.4
134
662
SPAT1255
SPAT
Intravenous administration of medicine
1.8
11.4
187
1049
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.6
11.4
299
1927
R02
ICPC
Shortness of breath/dyspnoea
1.6
11.4
305
1975
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
4.6
11.4
38
83
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
11.3
140
706
I44.0
ICD-10 Finland
Atrioventricular block, first degree
3.8
11.3
46
121
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
11.3
1223
10221
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
11.3
502
3635
C09DX04
ATC
valsartan and sacubitril; oral
4.2
11.2
41
98
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
11.2
168
915
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
5.7
11.1
31
55
I34
ICD-10 Finland
Nonrheumatic mitral valve disorders
20.1
11.1
16
8
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
8.6
11.0
23
27
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
10.9
258
1614
C10AA04
ATC
fluvastatin; oral
1.8
10.9
201
1170
J01DA01
ATC
[U] cefalexin; systemic
1.3
10.9
1913
16969
I20.09
ICD-10 Finland
Unstable angina
2.0
10.9
142
734
B01AF02
ATC
apixaban; oral
1.7
10.9
213
1264
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
3.5
10.9
49
141
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.1
10.8
126
625
N02AA05
ATC
oxycodone; systemic
1.5
10.7
337
2267
Z71.8
ICD-10 Finland
Other specified counselling
1.4
10.7
666
5120
Z49.2
ICD-10 Finland
Other dialysis
4.4
10.7
37
84
K90
ICPC
Stroke/cerebrovascular accident
2.8
10.7
67
242
24
HP
Multi-valve repair or other valve surgery
60.1
10.6
12
*
FPJ04
NOMESCO Finland
Revision of pacemaker generator with atrial and ventricular electrodes
8.0
10.6
23
29
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
10.5
1642
14340
Q25.21
ICD-10 Finland
Interrupted aortic arch
110.3
10.4
11
*
M03.6*I33.0
ICD-10 Finland
Arthropathy in infective endocarditis
110.3
10.4
11
*
FMA20
NOMESCO Finland
Plastic repair of aortic valve for stenosis
+∞
10.4
10
*
Q23.1
ICD-10 Finland
Congenital insufficiency of aortic valve
+∞
10.4
10
*
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
10.4
180
1030
FAE10
NOMESCO Finland
Bidirectional anastomosis between superior vena cava and pulmonary artery
32.6
10.3
13
*
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
5.0
10.3
32
65
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
10.3
339
2303
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
8.8
10.3
21
24
FM1BD
NOMESCO Finland
Extensive CT of heart
5.7
10.2
28
49
I31.1
ICD-10 Finland
Chronic constrictive pericarditis
23.4
10.2
14
6
AJX
HP
Other surgery on the heart or aorta
23.4
10.2
14
6
WZA90
NOMESCO Finland
Other doctors statement
1.4
10.2
693
5396
B34.9
ICD-10 Finland
Viral infection, unspecified
2.3
10.2
94
420
J01FA06
ATC
roxithromycin; oral
1.3
10.2
1150
9632
XA800
NOMESCO Finland
Neuropsychological investigation
1.8
10.2
161
892
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
10.1
192
1132
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
2.8
10.1
63
227
WX720
NOMESCO Finland
Own respiration
2.0
10.1
124
627
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
4.8
10.0
32
67
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
10.0
1179
9926
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
10.0
10.0
19
19
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.1
9.9
107
511
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
2.2
9.9
93
420
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.7
9.9
32
68
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
9.9
610
4677
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.6
9.9
42
116
I31.8
ICD-10 Finland
Other specified diseases of pericardium
12.2
9.8
17
14
FCC50
NOMESCO Finland
Resection and reconstruction of descending aorta using tube graft
26.1
9.8
13
5
FBE35
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery with insertion of stent
26.1
9.8
13
5
J98.5
ICD-10 Finland
Diseases of mediastinum, not elsewhere classified
10.6
9.8
18
17
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
9.8
92
417
ZXD35
NOMESCO Finland
Usual procedure
2.1
9.8
104
497
FNC20
NOMESCO Finland
Aorto-coronary venous bypass with two distal anastomoses
2.8
9.7
59
211
S18
ICPC
Laceration/cut
1.3
9.7
1210
10249
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
9.7
294
1959
N05CF01
ATC
zopiclone; oral
1.3
9.7
816
6562
XX7FW
NOMESCO Finland
NA
13.4
9.7
16
12
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
13.4
9.7
16
12
Q21.21
ICD-10 Finland
Atrioventricular duct
55.1
9.6
11
*
Q23.8
ICD-10 Finland
Other congenital malformations of aortic and mitral valves
55.1
9.6
11
*
42100
ICD-8 Finland
Acute and subacute endocarditis, Acute and subacute bacterial endocarditis
55.1
9.6
11
*
39501
ICD-8 Finland
Diseases of aortic valve, Cum insufficientia (febris rheumatica inactiva)
55.1
9.6
11
*
I72.8
ICD-10 Finland
Aneurysm and dissection of other specified arteries
7.8
9.6
21
27
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
6.8
9.6
23
34
FPD00
NOMESCO Finland
Maze procedure for atrial fibrillation
11.4
9.5
17
15
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
9.5
156
876
SPAT1301
SPAT
No procedures
1.3
9.5
829
6691
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
9.5
172
997
L28
ICPC
Limited function/disability (L)
1.5
9.5
318
2168
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.7
9.5
40
110
4210A
ICD-9 Finland
Acute and subacute endocarditis, Acute and subacute bacterial endocarditis
100.3
9.4
10
*
Q25.9
ICD-10 Finland
Congenital malformation of great arteries, unspecified
100.3
9.4
10
*
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
100.3
9.4
10
*
FAE00
NOMESCO Finland
Anastomosis to pulmonary artery from superior vena cava
100.3
9.4
10
*
4240A
ICD-9 Finland
Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]
30.1
9.4
12
*
3A077
NOMESCO Finland
NA
30.1
9.4
12
*
FCB40
NOMESCO Finland
Resection and reconstruction of aortic arch using tube graft
17.6
9.4
14
8
FXE00
NOMESCO Finland
Use of ECLA
17.6
9.4
14
8
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
9.4
192
1157
7451B
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Transposition of great vessels[DOUBLE OUTLET RIGHT VENTRICLE]
+∞
9.4
9
*
T82.6
ICD-10 Finland
Infection and inflammatory reaction due to cardiac valve prosthesis
+∞
9.4
9
*
R53
ICD-10 Finland
Malaise and fatigue
1.4
9.4
467
3451
K04
ICPC
Palpitations/awareness of heart
2.0
9.3
121
627
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
8.0
9.3
20
25
K02.1
ICD-10 Finland
Caries of dentine
1.2
9.3
1853
16549
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
3.8
9.3
37
97
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.5
9.3
70
283
AQ1
HP
Conventional electrophysiological examination
3.1
9.3
48
155
I15.8
ICD-10 Finland
Other secondary hypertension
9.5
9.2
18
19
Z01.7
ICD-10 Finland
Laboratory examination
1.5
9.2
296
2000
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
3.5
9.2
41
118
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
9.2
153
867
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
9.1
562
4307
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.9
9.1
53
184
A02BC01
ATC
omeprazole; systemic
1.3
9.1
706
5605
FM1DM
NOMESCO Finland
Heart very extensive MRI examination with 3 Tesla magnet
11.5
9.1
16
14
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
5.9
9.0
24
41
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
9.0
453
3351
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.6
9.0
232
1487
74729
ICD-8 Finland
Other congenital anomalies of circulatory system, Maleformationes aortae aliae
36.8
9.0
11
*
3AE00
NOMESCO Finland
NA
36.8
9.0
11
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
9.0
216
1363
Q23.3
ICD-10 Finland
Congenital mitral insufficiency
24.0
8.9
12
5
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
24.0
8.9
12
5
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
8.9
192
1173
Z3229
NOMESCO Finland
Other healthcare associate professional
1.6
8.9
223
1422
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
5.5
8.9
25
46
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
12.5
8.9
15
12
SPAT1079
SPAT
Echocardiography
3.5
8.8
39
112
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
8.8
1299
11194
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
4.9
8.8
27
55
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.3
8.7
81
364
FJF10
NOMESCO Finland
Replacement of pulmonary valve using biological prosthesis
50.1
8.7
10
*
74689
ICD-8 Finland
Congenital anomalies of heart, Aliae definitae
50.1
8.7
10
*
5207
FHL
VSD closure
50.1
8.7
10
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.9
8.7
122
653
N19
ICD-10 Finland
Unspecified kidney failure
2.4
8.6
72
307
H53.2
ICD-10 Finland
Diplopia
2.2
8.6
88
413
G47.3
ICD-10 Finland
Sleep apnoea
1.3
8.6
732
5884
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
3.7
8.5
35
95
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
8.5
134
746
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
8.5
264
1773
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.9
8.5
114
599
L04AA01
ATC
[U] ciclosporin; systemic
2.7
8.5
54
199
C09BA02
ATC
enalapril and diuretics; systemic
1.6
8.4
196
1226
4412A
ICD-9 Finland
Aortic aneurysm, Thoracic aneurysm without mention of rupture
90.2
8.4
9
*
I06.0
ICD-10 Finland
Rheumatic aortic stenosis
90.2
8.4
9
*
7470A
ICD-9 Finland
Other congenital anomalies of circulatory system, Patent ductus arteriosus
90.2
8.4
9
*
3950A
ICD-9 Finland
Diseases of aortic valve, Rheumatic aortic stenosis
90.2
8.4
9
*
SPAT1252
SPAT
Overall medication plan or its review
1.7
8.4
157
923
FN1AD
NOMESCO Finland
CT of coronary arteries
2.7
8.4
54
201
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.0
8.4
98
487
7AX01
NOMESCO Finland
NA
7.9
8.3
18
23
FCA20
NOMESCO Finland
Reinforcement of ascending aorta with wrapping
+∞
8.3
8
*
Q23.20
ICD-10 Finland
Congenital mitral stenosis
+∞
8.3
8
*
7465A
ICD-9 Finland
Other congenital anomalies of heart, Congenital mitral stenosis
+∞
8.3
8
*
FLE00
NOMESCO Finland
Excision of subvalvular membrane of left ventricle
+∞
8.3
8
*
B03XA01
ATC
erythropoietin; parenteral
3.9
8.3
32
82
ZXE90
NOMESCO Finland
More than 22 hours
5.0
8.3
25
50
RS221
NOMESCO Finland
NA
2.7
8.3
55
209
I72.1
ICD-10 Finland
Aneurysm and dissection of artery of upper extremity
10.7
8.3
15
14
I51.4
ICD-10 Finland
Myocarditis, unspecified
4.1
8.2
30
73
J01MA14
ATC
moxifloxacin; systemic
1.5
8.2
242
1603
N18.0
ICD-10 Finland
End-stage renal disease
3.2
8.2
40
124
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
7.1
8.2
19
27
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
3.9
8.2
32
83
J04AB02
ATC
rifampicin; systemic
3.1
8.2
43
141
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.2
8.2
80
369
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
8.1
553
4299
ZXA05
NOMESCO Finland
Left side
1.3
8.1
660
5266
0034
NOMESCO Finland
NA
33.4
8.1
10
*
FFC40
NOMESCO Finland
Closure of Patent Foramen Ovale
33.4
8.1
10
*
FFC00
NOMESCO Finland
Suture of ostium secundum type ASD
8.1
8.1
17
21
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
8.0
448
3371
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
2.6
8.0
56
219
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
1.8
8.0
130
731
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
8.0
188
1182
R03BB04
ATC
tiotropium bromide; inhalant
1.6
7.9
225
1478
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.1
7.9
88
428
C09CA03
ATC
valsartan; oral
1.5
7.9
234
1554
602
Kela drug reimbursment
Children's severe malnutrition
3.8
7.9
31
81
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
7.9
946
7931
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.8
7.9
127
712
474
NOMESCO Finland
NA
13.0
7.9
13
10
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
7.9
227
1497
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.2
7.9
76
351
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.7
7.8
50
186
C02CA01
ATC
prazosin; oral
3.2
7.8
38
119
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
3.6
7.7
33
93
XF405
NOMESCO Finland
Symptom ECG
3.7
7.7
32
88
3951A
ICD-9 Finland
Diseases of aortic valve, Rheumatic aortic insufficiency
45.0
7.7
9
*
221
HP
MVR mechanical
45.0
7.7
9
*
ABX
HP
Other aortic valve operation
45.0
7.7
9
*
5609
FHL
Other measure in this category
45.0
7.7
9
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.3
7.7
67
295
K60
ICPC
Cardiovascular, Result test/procedure
4.2
7.7
27
64
SPAT1251
SPAT
Organisation of medication
2.1
7.7
84
408
SPAT1312
SPAT
General health counselling
1.3
7.6
882
7361
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.8
7.6
130
741
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
3.2
7.6
38
121
I63.8
ICD-10 Finland
Other cerebral infarction
4.4
7.6
26
60
R00.0
ICD-10 Finland
Tachycardia, unspecified
1.9
7.6
101
530
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
7.6
197
1270
I42.5
ICD-10 Finland
Other restrictive cardiomyopathy
18.4
7.6
11
6
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.1
7.6
79
377
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
4.2
7.6
27
65
T82.8
ICD-10 Finland
Other specified complications of cardiac and vascular prosthetic devices, implants and grafts
25.0
7.6
10
*
FCB50
NOMESCO Finland
Resection of aortic arch and reimplantation of branches
25.0
7.6
10
*
72
HP
Catheter ablation of arrhythmia
4.9
7.6
23
47
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.6
7.6
190
1212
40199
ICD-8 Finland
Essential benign hypertension
3.3
7.5
36
111
N03AX16
ATC
pregabalin; oral
1.3
7.5
634
5079
I11
ICD-10 Finland
Hypertensive heart disease
5.1
7.5
22
43
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
3.3
7.5
35
106
FPH96
NOMESCO Finland
Other removal of cardiac pacemaker or cardioverter-defibrillator
5.7
7.5
20
35
FPE40
NOMESCO Finland
Replacement of transvenous cardiac pacemaker electrode
5.7
7.5
20
35
XF602
NOMESCO Finland
Bloodpressure monitoring
3.2
7.5
37
117
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
7.5
254
1741
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
3.0
7.5
40
134
3AC01
NOMESCO Finland
NA
3.1
7.5
38
123
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
7.4
334
2421
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.4
7.4
59
248
5284
FHL
Mitral defect correction with flap prosthesis or graft
80.2
7.4
8
*
7460C
ICD-9 Finland
Other congenital anomalies of heart, Anomalies of pulmonary valve[VITIUM VALVULAE PULMONALIS CONGENITA CUM STENOSIS]
80.2
7.4
8
*
FAE30
NOMESCO Finland
Total cavo-pulmonary connection using fenestrated patch
80.2
7.4
8
*
51
HP
Other heart surgery
80.2
7.4
8
*
SPAT1104
SPAT
Monitoring of emergency patient
1.6
7.4
174
1092
XQ903
NOMESCO Finland
Production of other scan or drawing
13.4
7.4
12
9
FXL00
NOMESCO Finland
Insertion and use of extra-, para- or intracorporeal VAD
7.6
7.4
16
21
-34
ICPC
Blood test
2.1
7.4
77
367
C01BA03
ATC
disopyramide; systemic
6.0
7.4
19
32
E05.89
ICD-10 Finland
Other thyrotoxicosis
5.6
7.4
20
36
-50
ICPC
Medication/prescr/renewal
1.9
7.3
101
537
B82
ICPC
Anaemia other/unspecified
2.5
7.3
55
225
K92.0
ICD-10 Finland
Haematemesis
2.2
7.3
67
303
H03BB01
ATC
carbimazole; oral
2.0
7.3
90
459
FDH96
NOMESCO Finland
Other operation for interrupted or hypoplastic aortic arch
+∞
7.3
7
*
39502
ICD-8 Finland
Diseases of aortic valve, Cum stenosi et insufficientia (febris rheumatica inactiva)
+∞
7.3
7
*
FCB96
NOMESCO Finland
Other repair of aortic arch
+∞
7.3
7
*
FMB96
NOMESCO Finland
Other expansion of aortic ostium
+∞
7.3
7
*
T82.0
ICD-10 Finland
Mechanical complication of heart valve prosthesis
+∞
7.3
7
*
AJ4
HP
Reconstruction of the descending thoracic aorta
+∞
7.3
7
*
I06.1
ICD-10 Finland
Rheumatic aortic insufficiency
+∞
7.3
7
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
7.3
234
1585
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
6.8
7.3
17
25
H02AB07
ATC
prednisone; oral
1.4
7.3
340
2484
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
4.1
7.3
26
63
FN1BD
NOMESCO Finland
Extensive CT of coronary arteries
9.4
7.3
14
15
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
7.3
158
971
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.2
7.3
67
304
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.6
7.3
168
1053
EB1WA
NOMESCO Finland
NA
3.7
7.2
29
78
K34
ICPC
Cardiovascular, Blood test
6.2
7.2
18
29
Q26.1
ICD-10 Finland
Persistent left superior vena cava
15.8
7.2
11
7
XX3CW
NOMESCO Finland
NA
15.8
7.2
11
7
GAB00
NOMESCO Finland
Emergency thoracotomy
15.8
7.2
11
7
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.2
7.2
71
330
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.1
7.2
37
121
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
7.2
192
1247
K73
ICPC
Congenital anomaly cardiovascular
30.0
7.1
9
*
74619
ICD-8 Finland
Congenital anomalies of heart, Transposition of great vessels
30.0
7.1
9
*
1EA01
NOMESCO Finland
NA
30.0
7.1
9
*
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
3.8
7.1
28
74
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.5
7.1
219
1469
FJF20
NOMESCO Finland
Replacement of pulmonary valve using homograft
20.0
7.1
10
5
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
20.0
7.1
10
5
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
7.1
85
431
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
7.9
7.1
15
19
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.7
7.1
127
737
FWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of heart and major thoracic vessels
12.0
7.1
12
10
WX902
NOMESCO Finland
External defibrillation of heart
5.3
7.1
20
38
TFP47
NOMESCO Finland
Ablation or modification of the AV-node
6.0
7.1
18
30
FM1EE
SPAT
NA
3.5
7.1
30
85
TFP35
NOMESCO Finland
Electroanatomical mapping
2.4
7.1
57
243
WX740
NOMESCO Finland
Nitrogen oxide therapy
5.6
7.0
19
34
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.4
7.0
56
235
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.8
7.0
116
658
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
10.0
7.0
13
13
H34.2
ICD-10 Finland
Other retinal artery occlusions
4.7
7.0
22
47
Z71.9
ICD-10 Finland
Counselling, unspecified
1.7
7.0
142
857
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
2.3
7.0
59
256
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
4.1
7.0
25
61
A28
ICPC
Limited function/disability NOS
1.5
7.0
259
1811
R4130
NOMESCO Finland
Speech therapy
2.2
6.9
64
289
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.5
6.9
52
213
FKC60
NOMESCO Finland
Resection and reconstruction of leaflet of mitral valve for insufficiency
4.6
6.9
22
48
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
2.6
6.9
48
187
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
1.6
6.8
173
1107
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.7
6.8
123
718
74
HP
Initial installation of the atrial pacemaker
8.3
6.8
14
17
4276B
ICD-9 Finland
Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]
8.3
6.8
14
17
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
6.8
745
6165
WX110
NOMESCO Finland
Local anesthesy
1.2
6.8
2236
20709
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
3.3
6.8
32
99
AF1
HP
Surgery of congenital heart defect
40.1
6.8
8
*
L04AD01
ATC
ciclosporin; systemic
2.2
6.7
65
299
WZA00
NOMESCO Finland
Short statement of of health and health related matters
1.6
6.7
164
1039
D82
ICPC
Teeth/gum disease
1.2
6.7
1017
8730
L04AX01
ATC
azathioprine; systemic
1.7
6.7
134
804
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.0
6.7
81
410
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
22.5
6.7
9
*
UKC02
NOMESCO Finland
Cystoscopy
1.4
6.7
386
2926
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
6.7
273
1946
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
6.6
70
338
SPAT1153
SPAT
Removal of sutures
1.2
6.6
853
7196
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
3.4
6.6
30
90
K05
ICPC
Irregular heartbeat other
2.2
6.6
62
284
B01AB10
ATC
tinzaparin; parenteral
1.6
6.6
169
1089
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.5
6.6
193
1282
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
6.6
231
1597
71
HP
Electrophysiological Special Examination
3.9
6.6
25
65
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.6
6.5
43
164
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
4.3
6.5
22
51
X57
ICD-10 Finland
Unspecified privation
2.2
6.5
64
300
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
6.5
2304
21444
C02EA01
ATC
NA
3.6
6.5
27
76
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.5
6.5
217
1487
I30.9
ICD-10 Finland
Acute pericarditis, unspecified
3.8
6.5
25
66
E66.01
ICD-10 Finland
Obesity due to excess calories
1.5
6.4
208
1413
Y0399
ICD-8 Finland
Investigation of circulatory system
3.1
6.4
32
103
WX730
NOMESCO Finland
Conventional respirator
2.5
6.4
46
184
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.4
181
1191
Q32.11
ICD-10 Finland
Congenital tracheo-esophageal fissure
69.9
6.4
7
*
324
NOMESCO Finland
NA
69.9
6.4
7
*
FCA40
NOMESCO Finland
Repair of ascending aorta using patch
69.9
6.4
7
*
I05.0
ICD-10 Finland
Mitral stenosis
69.9
6.4
7
*
Q25.4
ICD-10 Finland
Other congenital malformations of aorta
69.9
6.4
7
*
L17
ICPC
Foot/toe symptom/complaint
1.3
6.4
629
5132
RD210
NOMESCO Finland
NA
2.1
6.4
63
296
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
6.3
308
2263
R04.2
ICD-10 Finland
Haemoptysis
1.9
6.3
81
423
FKC96
NOMESCO Finland
Other repair of mitral valve for insufficiency
6.5
6.3
15
23
4270A
ICD-9 Finland
Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia
6.5
6.3
15
23
Q21.30
ICD-10 Finland
Tetralogy of Fallot
8.1
6.3
13
16
FBE32
NOMESCO Finland
Percutaneous transluminal angioplasty of pulmonary artery
8.1
6.3
13
16
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
3.1
6.3
31
99
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
6.3
309
2278
AH3
HP
Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery
11.0
6.3
11
10
I31.2
ICD-10 Finland
Haemopericardium, not elsewhere classified
11.0
6.3
11
10
FGE10
NOMESCO Finland
Replacement of tricuspid valve using biological prosthesis
18.0
6.3
9
5
FJE42
NOMESCO Finland
Percutaneous transluminal expansion of pulmonary valve
18.0
6.3
9
5
FDJ30
NOMESCO Finland
Reconstruction of aorta for coarctation using tube graft
+∞
6.2
6
*
3952A
ICD-9 Finland
Diseases of aortic valve, Rheumatic aortic stenosis with insufficiency
+∞
6.2
6
*
FKC61
NOMESCO Finland
Repair of mitral valve insufficiency by a transluminally inserted clip
+∞
6.2
6
*
FDH10
NOMESCO Finland
Reconstruction of interrupted or hypoplastic aortic arch using patch
+∞
6.2
6
*
39500
ICD-8 Finland
Diseases of aortic valve, Cum stenosi (febris rheumatica inactiva)
+∞
6.2
6
*
FJD96
NOMESCO Finland
Other operation on right ventricle outlet for congenital or acquired obstruction
+∞
6.2
6
*
FMB00
NOMESCO Finland
Supravalvular aortic expansion using patch
+∞
6.2
6
*
FMC00
NOMESCO Finland
Annuloplasty of aortic valve
+∞
6.2
6
*
FDA96
NOMESCO Finland
Other operation for HLHS
+∞
6.2
6
*
Q20.40
ICD-10 Finland
Double inlet left ventricle
26.7
6.2
8
*
I33
ICD-10 Finland
Acute and subacute endocarditis
26.7
6.2
8
*
K76
ICPC
Ischaemic heart dis without angina
2.2
6.2
59
271
WW500
NOMESCO Finland
Blood transfusion
1.8
6.2
101
570
K24
ICPC
Fear of heart disease
2.2
6.2
57
260
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.1
6.2
66
318
M01AB05
ATC
diclofenac; systemic, rectal
0.8
6.2
1821
19775
V03AE03
ATC
lanthanum carbonate; oral
4.5
6.1
20
45
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.0
6.1
70
350
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
12.5
6.1
10
8
I06.9
ICD-10 Finland
Rheumatic aortic valve disease, unspecified
12.5
6.1
10
8
Q25.78
ICD-10 Finland
Other congenital malformations of pulmonary artery
12.5
6.1
10
8
4341A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral embolism
12.5
6.1
10
8
R60.0
ICD-10 Finland
Localized oedema
1.5
6.1
225
1575
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
3.7
6.1
24
65
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.4
6.1
243
1724
K65.0
ICD-10 Finland
Acute peritonitis
2.9
6.0
33
114
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.7
6.0
119
714
FP2H5
NOMESCO Finland
ECG, telemetry
10.0
6.0
11
11
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
6.0
1734
15788
WX722
NOMESCO Finland
PEEP
1.6
6.0
139
872
H03AA01
ATC
levothyroxine sodium; systemic
1.3
6.0
491
3913
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3032080) INR in Blood by Coagulation assay
2622
12504
4.14
307.65
31.2
7.7
inr
1.9
1.2
100.88
775
3620
(3022217) INR in Platelet poor plasma by Coagulation assay
1251
3629
4.55
307.65
60.5
19.1
inr
2.2
1.2
23.63
121
553
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
981
2598
4.67
307.65
2.5
2.3
ug/l
15.7
8.6
11.26
937
2357
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
936
2280
5.04
307.65
3.6
2.8
ng/l
202.4
153.4
2.95
883
2035
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2533
7804
7.04
307.65
4.7
3.0
ng/l
1158.3
1102.3
0.25
2338
6552
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1444
5104
3.85
307.65
3.8
2.5
s
31.5
29.9
13.75
1419
4969
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
959
3502
3.28
201.77
4.3
5.0
u/l
293.6
245.3
9.93
924
3353
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
463
1034
4.93
195.08
8.6
3.8
u/ml
0.3
0.3
0.19
300
568
(3020779) Urea [Moles/volume] in Serum or Plasma
835
3157
3.07
162.36
12.1
9.5
mmol/l
9.3
8.8
1.11
804
3038
(3023368) Bacteria identified in Blood by Culture
1531
8284
2.37
141.50
5.9
4.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1691
9595
2.31
139.35
2.6
2.3
u/l
308.1
243.6
2.09
1630
9090
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1222
6037
2.47
137.96
5.3
3.6
ng/l
2309.2
553.7
1.90
1087
4523
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
418
1128
4.02
136.54
4.8
3.6
g/l
3.2
3.5
2.87
402
1078
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
950
4201
2.65
135.11
3.6
2.8
%
21.8
24.2
4.88
843
3665
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1932
11746
2.24
132.95
4.5
3.2
ng/l
58.6
50.8
0.51
1440
7659
(3004789) Transferrin [Mass/volume] in Serum or Plasma
983
4496
2.57
129.85
3.6
2.7
g/l
2.4
2.3
2.36
947
4232
(3013826) Glucose [Moles/volume] in Serum or Plasma
2719
19215
2.27
125.85
9.1
5.3
mmol/l
6.6
6.7
2.69
2619
18080
(3022948) Iron [Moles/volume] in Serum or Plasma
1019
4850
2.47
122.79
3.6
2.7
umol/l
12.8
13.9
4.67
972
4572
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1402
7707
2.26
120.79
3.0
2.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
784
3339
2.67
118.79
3.1
3.2
%
1.8
1.8
0.09
734
3014
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1082
5401
2.37
116.40
6.0
4.4
mmol/l
0.8
0.8
3.74
1035
5121
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
418
1268
3.56
114.54
6.0
3.2
%
88.1
91.0
1.52
408
1204
(3044640) Blood type and Crossmatch panel - Blood
1652
9914
2.13
112.07
3.2
2.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
116
103
11.57
111.61
8.7
7.2
—
—
—
0
0
(3044889) 12 lead EKG panel
3096
23626
2.34
111.22
5.9
3.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2221
14976
2.08
109.18
5.0
4.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2396
16617
2.09
109.04
7.7
6.9
umol/l
14.5
12.2
7.72
2303
15848
(3038071) Oxygen [Partial pressure] in Mixed venous blood
107
95
11.54
102.93
8.7
7.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
747
3325
2.53
102.03
15.6
9.4
%
96.7
95.8
4.20
734
3212
(3003396) Base excess in Arterial blood by calculation
797
3668
2.46
101.23
15.0
8.9
mmol/l
1.1
1.0
0.51
671
2894
(3014576) Chloride [Moles/volume] in Serum or Plasma
865
4146
2.38
100.27
11.4
8.5
mmol/l
105.3
104.4
7.25
853
4067
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
794
3680
2.44
99.11
15.0
8.9
kpa
5.2
5.1
0.50
769
3543
(3027801) Oxygen [Partial pressure] in Arterial blood
793
3679
2.44
98.74
15.0
8.9
kpa
13.3
12.6
2.38
767
3541
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
405
1320
3.30
98.63
2.1
1.8
g/l
1.3
1.5
4.13
274
1157
(3036489) Thrombin time
414
1405
3.17
94.14
3.8
2.9
s
22.8
21.8
1.39
378
1241
(3002173) Hemoglobin [Mass/volume] in Arterial blood
692
3111
2.48
91.74
15.5
9.7
g/l
115.6
124.4
21.89
677
3007
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
356
1121
3.39
91.45
3.7
3.3
%
188.1
187.0
0.08
347
1069
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1244
7182
2.06
89.15
2.6
2.3
mg/l
3.1
2.8
4.59
1107
6217
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2006
13995
1.86
79.30
12.5
7.1
mmol/l
1.2
1.2
29.29
1895
12861
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
514
2142
2.60
79.24
16.7
11.2
%
0.7
0.7
0.39
514
2125
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2128
15304
1.83
74.49
13.0
7.8
mmol/l
1.2
1.2
34.08
1853
13099
(3023520) Reticulocytes [#/volume] in Blood
559
2503
2.43
73.68
3.2
3.0
e9/l
74.7
71.9
0.93
418
1851
(3033658) Prothrombin time (PT) actual/Normal
1377
8712
1.88
72.46
6.4
4.5
%
74.2
91.0
63.74
1349
8515
(3014111) Lactate [Moles/volume] in Serum or Plasma
622
2941
2.32
72.35
14.5
9.2
mmol/l
1.3
1.4
0.83
609
2831
(3012544) pH of Venous blood
684
3379
2.23
71.59
7.1
5.2
ph
7.3
7.4
—
5
17
(3000991) Gas panel - Venous blood
638
3075
2.28
70.82
15.9
10.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1906
13400
1.80
70.59
7.4
5.6
g/l
35.4
36.1
4.77
1805
12604
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
192
486
4.10
67.70
9.0
7.1
mg/l
10.9
11.2
0.46
174
456
(3006576) Bicarbonate [Moles/volume] in Blood
92
118
7.95
67.24
9.2
7.9
mmol/l
25.3
24.9
0.38
83
110
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
440
1840
2.56
66.84
21.8
12.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
848
4718
2.01
64.26
2.6
2.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
815
4484
2.02
63.67
11.1
7.4
mmol/l
1.1
1.1
3.22
789
4235
(3024928) Oxygen saturation in Venous blood
238
736
3.37
62.51
7.0
4.9
—
—
—
0
0
(3013512) EKG study
1351
8823
1.80
62.00
5.5
3.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3044
25136
1.86
60.62
9.8
7.7
u/l
80.0
79.5
0.28
2928
23885
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
68
69
10.01
59.60
10.0
8.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
3837
34712
3.19
58.76
28.5
14.9
mmol/l
139.4
139.7
16.20
3792
33937
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1636
11508
1.71
56.43
3.8
3.5
u/l
38.8
36.4
0.43
1573
10943
(3023103) Potassium [Moles/volume] in Serum or Plasma
3839
34847
3.13
56.30
28.8
15.0
mmol/l
4.0
4.0
11.33
3790
34012
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1136
7230
1.80
55.70
3.0
2.0
mg/l
1.4
1.2
1.16
857
5516
(3004119) Hemoglobin [Mass/volume] in Venous blood
429
1926
2.37
55.45
6.9
4.3
g/l
123.2
131.7
9.74
419
1882
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
398
1736
2.43
54.85
18.8
12.1
mmol/l
24.5
24.3
0.90
373
1658
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
812
4702
1.91
53.64
2.0
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1803
13139
1.67
53.58
3.8
2.8
ug/l
165.0
146.7
0.28
1710
12328
(3027456) Digoxin [Moles/volume] in Serum or Plasma
144
351
4.22
53.36
2.6
2.9
nmol/l
0.8
0.8
0.72
110
260
(3019060) Gas panel - Arterial blood
446
2070
2.30
53.30
9.9
5.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
618
3275
2.05
52.68
6.6
5.2
kpa
5.8
5.9
0.44
605
3186
(3002032) Base excess in Venous blood by calculation
616
3277
2.04
51.90
6.8
5.2
mmol/l
1.7
1.8
0.52
518
2649
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
203
642
3.28
51.34
1.7
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
422
1991
2.25
48.31
13.4
7.8
mmol/l
24.5
24.5
0.01
402
1858
(3006315) Basophils [#/volume] in Blood
2166
16866
1.61
47.06
7.9
6.6
e9/l
0.0
0.0
0.57
1923
14634
(3013115) Eosinophils [#/volume] in Blood
2221
17438
1.61
46.31
8.2
6.8
e9/l
0.2
0.2
0.02
1997
15381
(3001604) Monocytes [#/volume] in Blood
2154
16811
1.60
45.86
7.8
6.5
e9/l
0.6
0.6
3.30
1911
14584
(3019198) Lymphocytes [#/volume] in Blood
2196
17319
1.59
43.92
7.9
6.6
e9/l
1.8
2.0
10.57
1977
15318
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
280
1154
2.53
43.35
3.6
2.6
ug/l
492.2
512.2
0.05
273
1099
(42870588) Differential panel, method unspecified - Blood
1564
11444
1.60
42.70
7.8
6.7
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
37
24
15.55
42.56
6.8
4.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3719
33885
2.26
42.55
22.9
13.2
mg/l
28.7
23.5
16.69
3243
26352
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
403
1961
2.17
42.54
6.5
5.8
mmol/l
23.9
24.0
0.28
364
1806
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
288
1214
2.48
42.49
2.5
2.1
ug/l
1.9
2.2
0.15
265
1110
(3024354) Oxygen [Partial pressure] in Venous blood
506
2715
1.99
41.01
5.5
4.7
kpa
4.9
4.8
0.37
495
2630
(3013650) Neutrophils [#/volume] in Blood by Automated count
2369
19255
1.56
39.65
10.5
9.9
e9/l
4.2
4.0
2.76
2120
16805
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
505
2749
1.96
39.16
2.6
2.5
ml/min/173m2
62.2
70.5
4.07
209
1004
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
574
3277
1.88
38.50
1.9
1.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
316
1463
2.26
37.59
5.1
3.9
%
0.7
0.7
0.58
304
1403
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
574
3309
1.86
37.25
2.0
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2830
24104
1.58
37.23
5.0
4.0
mm/h
12.4
10.6
7.61
2688
22557
(3021589) Normoblasts [#/volume] in Blood
1919
15097
1.52
35.77
13.0
9.8
e9/l
0.0
0.0
0.60
1625
12353
(3018418) pH of Serum or Plasma
1232
8813
1.57
35.45
6.3
4.4
ph
7.4
7.4
0.14
283
1721
(3006504) Eosinophils/100 leukocytes in Blood
1977
15735
1.50
34.31
8.2
6.8
%
2.9
2.9
0.28
1886
14826
(3019069) Monocytes/100 leukocytes in Blood
1987
15833
1.50
34.28
8.5
7.1
%
9.0
8.7
4.07
1898
14981
(3022096) Basophils/100 leukocytes in Blood
1928
15297
1.50
33.78
8.2
6.8
%
0.7
0.7
0.00
1840
14431
(3020891) Body temperature
281
1310
2.23
32.79
7.5
5.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
1996
16081
1.48
31.58
8.1
6.6
%
58.9
56.1
21.09
1909
15215
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
41
50
8.27
31.22
11.0
5.4
%
62.0
79.1
3.24
34
38
(3002030) Lymphocytes/100 leukocytes in Blood
2018
16332
1.47
30.95
8.2
6.8
%
25.8
28.9
32.25
1924
15386
(3043409) Potassium [Moles/volume] in Arterial blood
223
974
2.36
30.31
6.6
4.6
mmol/l
4.1
3.9
5.19
213
924
(3031040) Bacteria [#/volume] in Urine by Automated count
2359
19727
1.47
30.28
4.6
3.9
e6/l
147.8
748.8
1.13
38
240
(3018405) Lactate [Moles/volume] in Arterial blood
250
1149
2.25
30.17
6.2
4.4
mmol/l
1.3
1.4
0.55
250
1130
(40758558) Short blood count panel - Blood
1183
8664
1.52
29.46
7.6
7.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3800
35600
2.17
29.45
21.8
12.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
157
592
2.72
29.04
1.3
1.2
u/ml
5.5
3.6
0.30
64
200
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
224
1000
2.31
28.95
2.3
1.9
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
70
157
4.52
28.93
11.7
8.1
mg/l
2673.7
69.1
0.50
58
123
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1338
10089
1.49
28.77
3.4
2.7
u/l
57.5
58.3
0.15
1253
9418
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
153
578
2.71
28.20
1.3
1.2
u/ml
6.2
4.5
0.59
78
254
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
193
822
2.42
27.75
9.4
7.0
iu/ml
461.0
535.2
0.11
42
128
(3007853) Bacteria identified in Skin by Aerobe culture
614
3908
1.67
27.64
2.0
1.8
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
247
1191
2.14
26.44
7.3
7.1
mg/l
1.6
1.4
2.33
231
1123
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
375
2097
1.87
26.38
1.9
1.7
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1273
9632
1.47
26.37
3.8
3.3
e6/l
219.0
88.3
0.56
1008
7383
(3051593) INR in Capillary blood by Coagulation assay
52
101
5.20
25.47
13.2
10.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
510
3155
1.71
25.41
3.7
3.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3455
31729
1.62
24.76
19.9
12.0
ml/min/173m2
83.4
85.1
4.59
3051
26240
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
595
3857
1.64
24.74
10.5
6.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
916
6556
1.51
24.71
3.2
2.7
e6/l
4.0
4.7
1.30
809
5766
(3018095) Leukocytes [#/volume] in Urine
1421
11112
1.43
24.20
4.3
3.7
e6/l
60.4
71.3
0.26
1069
7920
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
406
2387
1.78
24.18
6.6
4.8
kpa
5.1
5.1
0.35
376
2229
(3030467) Casts [#/volume] in Urine by Automated count
1171
8850
1.46
23.91
3.7
3.2
e6/l
0.4
0.4
0.08
903
6621
(3035510) Gentamicin [Mass/volume] in Serum or Plasma
21
14
15.07
23.64
5.5
3.3
mg/l
1.0
0.7
—
14
9
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
154
637
2.47
23.62
4.3
4.1
u/ml
139.2
1314.4
—
6
45
(3009343) pH of Capillary blood
400
2358
1.77
23.59
6.7
4.9
ph
7.4
7.4
0.58
57
256
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
389
2280
1.78
23.39
6.7
4.9
mmol/l
1.7
1.5
0.45
304
1708
(36304419) Bacteria [Presence] in Urine
1150
8699
1.45
23.24
3.5
3.1
—
—
—
0
0
(4268621)
112
402
2.84
22.80
2.5
2.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
584
3869
1.60
22.03
3.7
3.3
umol/l
10.7
8.1
1.43
523
3431
(3023183) Ammonium ion [Moles/volume] in Plasma
186
862
2.21
21.99
3.4
3.3
umol/l
37.7
36.7
0.18
169
767
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
369
2179
1.76
21.58
6.6
4.7
ng/l
131.2
87.9
5.88
339
1965
(3012501) Base excess in Blood by calculation
165
734
2.30
21.52
5.9
4.9
mmol/l
2.4
2.3
0.09
105
495
(3027273) Bicarbonate [Moles/volume] in Venous blood
270
1451
1.92
21.38
6.3
3.9
mmol/l
25.0
25.2
0.30
265
1406
(3037467) Urinalysis macro (dipstick) panel - Urine
2480
21605
1.38
21.14
4.8
3.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
66
180
3.71
21.07
4.9
4.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1219
9465
1.41
20.87
1.4
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
297
1661
1.85
20.79
1.5
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3269
29952
1.48
20.50
4.9
4.2
mu/l
1.9
2.3
1.47
3064
27731
(3010421) pH of Blood
180
854
2.16
20.09
5.7
5.0
ph
7.4
7.4
0.65
161
722
(3028308) Erythrocytes [#/volume] in Pleural fluid
85
282
3.06
19.95
1.5
1.5
e6/l
61599.4
78998.1
0.26
55
167
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
498
3249
1.61
19.91
3.0
2.6
g/l
0.2
0.2
3.63
464
3056
(3026782) Osmolality of Urine
836
6103
1.47
19.87
3.3
2.8
mosm/kgh2o
551.7
567.8
1.16
725
5242
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
236
1252
1.94
19.41
12.7
5.8
%
1.8
1.7
0.36
225
1166
(3023199) Leukocytes [#/volume] in Pleural fluid
91
321
2.88
19.17
1.5
1.5
e6/l
6687.7
2646.2
0.46
71
232
(3019309) Folate [Moles/volume] in Red Blood Cells
672
4732
1.50
19.04
1.8
1.7
nmol/l
1293.9
1164.7
2.84
537
3687
(3009445) Proteinase 3 Ab [Units/volume] in Serum
263
1456
1.86
19.00
1.5
1.5
u/ml
16.1
17.1
—
10
41
(3020630) Protein [Mass/volume] in Serum or Plasma
389
2420
1.67
18.75
2.1
2.8
g/l
66.1
66.7
0.83
361
2254
(3000494) Fungus identified in Specimen by Culture
587
4036
1.53
18.58
1.8
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
753
5462
1.47
18.33
2.9
2.8
e6/l
0.7
0.9
2.25
449
3067
(3029937) Albumin [Presence] in Urine by Test strip
1058
8182
1.40
18.03
4.7
3.6
estimate
0.0
0.0
0.60
344
2781
(3021960) Folate [Moles/volume] in Serum or Plasma
848
6310
1.44
17.99
1.6
1.5
nmol/l
19.1
20.2
1.32
746
5482
(3022313) Gas panel - Capillary blood
307
1811
1.75
17.96
6.9
4.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
94
351
2.72
17.83
1.5
1.5
g/l
31.9
33.4
0.49
86
314
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2733
24489
1.36
17.63
4.1
3.6
pmol/l
15.0
14.7
8.58
2542
22551
(3039000) Anion gap in Blood
154
727
2.16
17.44
17.5
7.9
mmol/l
10.6
11.5
3.35
145
651
(3018572) Chloride [Moles/volume] in Blood
154
728
2.16
17.38
17.5
7.9
mmol/l
106.0
105.2
1.28
145
652
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
173
858
2.06
17.23
1.8
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1154
9110
1.37
17.21
3.4
2.7
umol/l
1935.2
3606.0
1.42
1043
8096
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
169
834
2.07
17.06
1.8
1.9
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
217
1179
1.89
16.63
1.6
1.6
titre
157.5
258.2
—
6
45
(1616796) Gas panel - Central venous blood
148
703
2.15
16.51
6.4
4.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
225
1241
1.86
16.45
13.2
5.9
%
0.9
0.9
1.08
214
1158
(3017143) Hepatitis C virus Ab [Presence] in Serum
580
4076
1.49
16.41
1.9
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
291
1736
1.73
16.35
1.5
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
149
716
2.12
16.14
1.6
1.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
198
1055
1.92
16.10
2.1
1.5
g/l
1.2
1.2
0.66
180
1008
(3035350) Ketones [Presence] in Urine by Test strip
1814
15453
1.32
15.81
4.2
3.3
estimate
0.0
0.0
0.80
356
2806
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
275
1631
1.74
15.77
7.5
5.1
mmol/l
24.8
24.6
0.79
265
1544
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
189
1011
1.91
15.20
2.2
1.5
g/l
0.2
0.2
0.04
171
966
(3037522) Nuclear Ab [Titer] in Serum
636
4617
1.45
15.16
1.4
1.3
titre
467.6
469.7
0.01
136
856
(3024932) HLA-DR beta [Type]
57
176
3.27
15.15
1.1
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
57
178
3.23
14.88
1.0
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1224
9934
1.33
14.76
3.7
3.6
mmol/l
2.3
2.4
1.72
1086
8864
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
156
790
2.01
14.71
2.0
1.6
u/ml
107.9
113.0
0.25
40
134
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
46
126
3.68
14.68
1.7
1.8
%
195.5
171.2
0.59
46
121
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
367
2390
1.59
14.64
5.4
4.4
mmol/l
1.2
1.2
2.05
334
2122
(3047181) Lactate [Moles/volume] in Blood
189
1028
1.88
14.46
15.7
6.7
mmol/l
1.3
1.3
0.58
173
894
(3011648) Oxygen content in Venous blood
83
327
2.57
14.23
5.1
5.5
%
11.3
11.6
0.25
83
327
(3012441) Differential panel - Pleural fluid
74
276
2.71
14.14
1.5
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
138
679
2.07
14.09
3.4
2.7
%
16.7
16.9
0.18
73
355
(3000093) Morphology [Interpretation] in Blood Narrative
81
319
2.57
13.90
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
636
4689
1.42
13.84
1.8
1.6
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
65
229
2.87
13.82
27.2
28.6
ug/l
127.7
129.0
0.05
50
189
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
192
1065
1.84
13.82
1.7
1.8
—
—
—
0
0
(44790047)
102
449
2.30
13.75
1.8
1.7
—
—
—
0
0
(44790048)
102
449
2.30
13.75
1.8
1.7
—
—
—
0
0
(44790049)
102
449
2.30
13.75
1.8
1.7
—
—
—
0
0
(44806118)
102
449
2.30
13.75
1.8
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
294
1844
1.64
13.67
3.6
3.4
pmol/l
4.4
4.5
1.04
262
1662
(3002385) Erythrocyte distribution width [Ratio]
3108
28795
1.35
13.57
27.9
16.1
%
13.8
13.6
13.06
3069
28199
(3021601) Nitrite [Presence] in Urine by Test strip
1794
15469
1.29
13.49
5.5
4.4
estimate
0.0
0.0
0.80
366
2927
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
685
5139
1.40
13.46
3.1
3.0
e6/l
1.7
1.7
0.03
384
2755
(3015235) Bicarbonate [Moles/volume] in Capillary blood
157
830
1.93
13.11
4.0
4.1
mmol/l
24.0
24.7
1.22
134
724
(3005719) IgG [Mass/volume] in Serum or Plasma
407
2779
1.52
13.11
3.1
2.8
g/l
10.7
10.5
0.57
370
2563
(3026008) Bacteria identified in Urine by Culture
923
7291
1.34
13.10
3.2
2.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1807
15636
1.28
13.07
4.3
3.3
estimate
0.0
0.0
0.12
356
2747
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
52
167
3.14
13.01
1.7
1.7
%
159.1
151.4
0.29
52
158
(3034426) Prothrombin time (PT)
49
152
3.25
12.97
1.2
1.3
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
49
152
3.25
12.97
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
48
147
3.29
12.97
1.2
1.1
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
24
43
5.61
12.88
4.8
4.5
%
3.9
5.7
—
8
19
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1401
11757
1.29
12.81
2.0
1.9
pmol/l
95.5
96.0
0.15
796
6455
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
158
850
1.89
12.54
2.1
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
125
622
2.04
12.42
1.8
2.0
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
24
45
5.36
12.28
1.2
1.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
93
414
2.28
12.25
1.3
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
158
857
1.88
12.23
2.0
1.6
u/ml
10.2
18.4
—
8
19
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
95
428
2.25
12.17
2.6
2.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
201
1175
1.75
12.16
1.9
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
56
198
2.85
11.88
2.5
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
170
954
1.82
11.82
4.4
3.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
364
2481
1.51
11.80
4.8
3.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
905
7230
1.32
11.71
4.2
3.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
189
1098
1.76
11.70
7.5
5.9
kpa
8.9
8.8
0.04
178
1022
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
58
211
2.77
11.68
1.2
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
132
687
1.95
11.58
2.9
2.4
g/l
130.3
132.8
0.46
97
502
(3020682) Albumin/Creatinine [Ratio] in Urine
1209
10068
1.29
11.44
4.7
4.0
mg/mmol
18.1
10.8
1.82
827
6651
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
123
631
1.98
11.26
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
123
631
1.98
11.26
1.4
1.3
—
—
—
0
0
(4010399)
342
2324
1.52
11.25
1.5
1.4
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
49
166
2.98
11.24
1.2
1.1
iu/ml
3.8
3.9
—
5
12
(3028026) IgM [Mass/volume] in Serum or Plasma
323
2171
1.53
11.18
1.7
1.9
g/l
1.1
1.2
0.67
298
2021
(3012516) Albumin [Mass/volume] in Urine
1157
9608
1.29
11.13
3.9
3.3
mg/l
296.4
363.5
0.25
808
6334
(3002256) Pathology report gross observation
538
3999
1.40
11.02
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
157
882
1.81
10.90
1.5
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
63
250
2.54
10.73
1.4
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
103
505
2.07
10.70
1.8
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
149
829
1.83
10.69
1.5
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
75
324
2.34
10.64
5.4
3.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1251
10537
1.27
10.63
3.8
3.4
mmol/l
7.5
8.4
8.95
1101
9068
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3445
32727
1.36
10.51
4.9
3.9
mmol/l
1.4
1.4
0.49
3284
30620
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3282
30978
1.32
10.30
6.2
5.4
mmol/mol
39.4
39.7
0.55
3133
29157
(3034860) Kappa light chains.free [Mass/volume] in Serum
151
854
1.80
10.28
2.8
3.7
mg/l
66.2
57.7
0.28
125
685
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
151
855
1.80
10.24
2.8
3.6
mg/l
38.2
60.4
0.76
126
687
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
149
842
1.80
10.17
1.6
1.4
u/ml
262.5
254.8
0.13
113
507
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
148
840
1.79
9.96
2.7
3.6
ratio
12.8
1.6
0.96
11
73
(3019768) Coxiella burnetii Ab [Presence] in Serum
17
28
6.09
9.92
1.5
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
104
529
1.99
9.80
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
105
536
1.98
9.80
1.5
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
15
22
6.84
9.73
1.7
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
184
1120
1.67
9.67
1.4
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
21
44
4.79
9.52
1.6
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
96
480
2.02
9.50
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
56
224
2.52
9.43
6.1
4.1
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
29
79
3.69
9.42
2.0
1.3
%
101.9
107.4
0.29
29
74
(21494890) Protein electrophoresis panel - 24 hour Urine
69
304
2.29
9.40
1.6
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
729
5816
1.31
9.29
2.1
1.8
—
—
—
0
0
(4306422)
110
584
1.91
9.18
1.2
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1392
12030
1.24
9.13
4.5
3.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
108
574
1.91
8.99
3.9
3.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
825
6719
1.29
8.96
4.7
3.5
kg/l
1.0
1.0
0.29
110
917
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
156
928
1.71
8.95
1.8
1.4
iu/ml
12.9
9.6
—
10
17
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
47
177
2.67
8.95
1.4
1.3
u/l
14.9
12.4
0.25
41
168
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
84
410
2.07
8.90
1.8
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
123
684
1.82
8.90
1.7
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
636
5013
1.32
8.81
2.8
3.2
mmol/l
2.4
2.4
0.02
540
4419
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
17
32
5.33
8.67
1.5
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3539
33945
1.35
8.61
5.3
4.4
mmol/l
4.5
4.7
39.53
3400
32063
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3764
36487
1.48
8.54
14.1
10.2
u/l
29.1
29.5
0.51
3674
35434
(3021879) Hepatitis B virus core Ab [Presence] in Serum
366
2660
1.41
8.49
1.5
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
63
280
2.27
8.45
1.6
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
913
7594
1.26
8.27
5.6
4.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3519
33762
1.33
8.25
5.3
4.3
mmol/l
1.4
1.4
9.59
3372
31736
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
31
97
3.21
8.20
4.6
6.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3572
34354
1.35
8.16
5.8
4.7
mmol/l
2.6
2.8
33.64
3431
32276
(3004588) Protein electrophoresis panel - Serum or Plasma
280
1954
1.47
8.10
1.9
2.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
161
999
1.64
7.91
2.3
1.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
310
4253
0.71
7.85
1.3
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
230
1555
1.51
7.79
3.3
2.9
e6/l
0.2
0.3
0.12
224
1514
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
97
523
1.88
7.78
1.5
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
186
1201
1.58
7.76
1.3
1.2
u/ml
1.6
0.8
0.25
23
100
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3395
32491
1.28
7.53
5.0
4.3
mmol/l
6.0
6.0
0.13
3193
30149
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
32
108
2.98
7.49
1.2
1.2
%
67.9
85.1
1.19
20
57
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
118
685
1.74
7.45
3.4
3.9
%
59.3
56.7
1.56
118
685
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
105
590
1.80
7.41
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
151
941
1.63
7.32
1.2
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
87
464
1.89
7.25
1.4
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
18
42
4.30
7.21
2.0
2.1
ng/l
126.9
157.0
0.34
18
42
(3037121) Protein [Mass/volume] in Urine
176
1143
1.56
7.19
3.9
4.2
g/l
0.4
0.3
0.67
98
581
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
26
80
3.26
7.09
1.3
1.1
%
82.5
80.3
0.12
11
28
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
108
623
1.75
6.99
1.6
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
112
656
1.73
6.88
3.0
3.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
865
7284
1.24
6.87
1.3
1.3
u/ml
2.3
2.0
0.23
262
1890
(3007164) IgA [Mass/volume] in Serum or Plasma
801
6691
1.25
6.84
1.5
1.5
g/l
2.7
2.4
2.70
554
4200
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
124
749
1.68
6.81
1.3
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
25
78
3.22
6.69
1.2
1.1
%
74.1
72.4
—
10
27
(40761536) Microorganisms panel - Urine sediment
348
2613
1.36
6.66
4.6
3.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
252
1793
1.43
6.62
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
98
559
1.77
6.62
6.8
4.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
31
111
2.81
6.57
1.1
1.0
%
69.8
88.6
2.07
19
59
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
110
653
1.70
6.46
1.3
1.2
u/ml
3.3
9.1
—
5
6
(40768446) Kidney Pathology biopsy report
44
190
2.33
6.39
1.8
1.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
158
1032
1.55
6.33
2.9
2.6
—
—
—
0
0
(3000492) Spirometry study
462
3646
1.30
6.27
1.6
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
726
6059
1.24
6.21
1.6
1.6
pmol/l
54880432.5
34635229.6
0.30
625
5148
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
63
320
1.98
6.11
1.7
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
173
2512
0.67
6.00
1.6
1.5
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
14
31
4.53
5.98
1.9
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3903
38330
1.57
5.97
33.9
19.2
e9/l
235.7
249.3
35.44
3847
37431
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
107
645
1.68
5.97
1.2
1.2
u/ml
2.6
7.2
—
7
45
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
71
380
1.88
5.92
1.9
2.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1038
9020
1.20
5.92
1.7
1.7
mmol/l
1.5
1.4
1.04
916
7665
(3000570) Elastase.pancreatic [Mass/mass] in Stool
144
937
1.56
5.89
1.4
1.4
ug/g
237.8
273.9
1.39
79
556
(3037756) Immunofixation for Serum or Plasma
97
573
1.71
5.84
1.6
1.8
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
54
264
2.06
5.83
1.8
2.1
—
1.4
—
0
19
(3042010) Triglyceride [Moles/volume] in Pleural fluid
17
45
3.79
5.80
1.5
1.3
mmol/l
0.4
0.9
—
7
35
(3048929) Epstein Barr virus Ab [Presence] in Serum
185
1274
1.47
5.80
1.6
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
292
3856
0.74
5.80
1.8
1.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
127
806
1.59
5.79
1.3
1.2
u/ml
3.6
6.9
0.32
12
74
(3035285) Chloride [Moles/volume] in Venous blood
63
327
1.94
5.77
3.6
2.4
mmol/l
105.9
105.6
0.22
63
322
(3004451) EKG impression Narrative
39
168
2.33
5.73
1.2
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
63
328
1.94
5.72
3.6
2.4
mmol/l
4.1
4.1
0.00
63
323
(3011985) Renin [Units/volume] in Plasma
79
445
1.79
5.62
1.3
1.4
mu/l
145.3
77.3
0.60
67
406
(3024731) MCV [Entitic volume]
3903
38357
1.55
5.62
33.7
19.1
fl
90.7
90.6
0.87
3875
37926
(3026361) Erythrocytes [#/volume] in Blood
3903
38359
1.55
5.59
33.8
19.2
e12/l
4.5
4.6
64.75
3841
37369
(3033705) Calcium.ionized [Moles/volume] in Venous blood
61
317
1.94
5.58
3.7
2.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
154
1032
1.51
5.53
1.3
1.3
titre
92.6
102.5
0.15
19
91
(3035941) MCH [Entitic mass]
3902
38352
1.54
5.53
33.7
19.1
pg
30.2
30.3
3.87
3875
37921
(3010813) Leukocytes [#/volume] in Blood
3903
38365
1.54
5.52
33.9
19.2
e9/l
6.8
6.7
4.77
3839
37370
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
127
816
1.57
5.52
1.3
1.2
u/ml
13.1
7.6
0.37
22
114
(3000963) Hemoglobin [Mass/volume] in Blood
3903
38370
1.54
5.45
34.3
19.3
g/l
133.3
139.3
94.64
3872
37938
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
75
420
1.80
5.45
1.9
1.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
209
1494
1.42
5.40
2.0
2.0
u/l
40.2
39.4
0.20
173
1339
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
16
43
3.73
5.36
3.4
5.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
341
2639
1.32
5.35
4.5
4.6
%
0.2
0.2
0.01
112
749
(3040151) Glucose [Moles/volume] in Capillary blood
64
345
1.87
5.26
9.5
5.1
mmol/l
6.7
7.2
0.71
58
288
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
74
422
1.77
5.09
1.2
1.4
pmol/l
332.4
310.5
0.15
59
332
(3036481) Cortisol [Moles/volume] in Serum or Plasma
387
3071
1.29
5.05
2.4
2.4
nmol/l
373.3
362.2
0.33
363
2875
(3011412) CD3 cells [#/volume] in Blood
70
394
1.79
5.03
2.5
3.0
e9/l
0.9
1.2
2.44
40
241
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
90
544
1.67
5.03
1.1
1.1
g/l
1.6
1.5
0.97
79
497
(3041918) Cholesterol [Moles/volume] in Pleural fluid
18
55
3.28
5.02
1.2
1.2
mmol/l
1.5
1.6
—
10
37
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
399
3182
1.28
5.01
2.9
2.7
u/l
43.6
53.4
0.25
343
2793
(3003181) Sodium [Moles/volume] in Urine
87
522
1.68
5.00
1.6
1.5
mmol/l
64.2
65.9
0.12
71
422
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
25
94
2.67
4.90
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
353
2783
1.29
4.85
4.6
4.5
%
1.4
0.9
0.91
118
816
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1379
12447
1.16
4.83
2.8
2.3
nmol/l
75.9
74.9
0.76
1268
11410
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
49
249
1.98
4.82
1.7
1.8
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
138
935
1.49
4.76
2.1
2.1
mg/l
13.4
10.8
0.77
128
878
(3000012) Reticulocyte production index
35
157
2.24
4.74
1.1
1.6
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1236
13695
0.86
4.63
3.1
2.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
57
310
1.85
4.61
3.2
2.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
22
80
2.76
4.60
1.5
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
54
291
1.87
4.50
2.7
3.3
e9/l
0.2
0.2
0.16
43
249
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
129
873
1.49
4.49
1.3
1.2
u/ml
28.8
41.3
—
8
44
(3039162) Centromere protein B Ab [Units/volume] in Serum
68
394
1.74
4.47
1.2
1.2
u/ml
39.2
55.3
—
8
18
(3016650) Hepatitis A virus Ab [Presence] in Serum
97
617
1.59
4.47
1.1
1.1
—
—
—
0
0
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
9
12
7.51
4.35
7.2
9.5
%
47.4
55.3
—
9
6
(42529406) Shigella sp [Presence] in Stool by Culture
134
923
1.47
4.29
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
133
915
1.47
4.29
1.3
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
68
400
1.71
4.26
2.6
2.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
55
304
1.82
4.25
1.6
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
55
304
1.82
4.25
1.6
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
55
304
1.82
4.25
1.6
1.9
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
34
159
2.15
4.20
1.2
1.1
u/l
61.0
22.4
0.53
29
121
(3035880) pH of Pleural fluid
32
146
2.20
4.20
1.3
1.4
—
—
—
0
0
(3019225) pH of Specimen
354
2845
1.27
4.20
5.9
4.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
57
320
1.79
4.20
2.0
2.8
%
14.7
12.6
0.46
31
176
(3024139) IgG subclass 3 [Mass/volume] in Serum
67
395
1.71
4.17
1.6
1.3
g/l
0.4
0.4
0.29
47
278
(3027135) IgG subclass 1 [Mass/volume] in Serum
67
395
1.71
4.17
1.6
1.3
g/l
7.6
6.6
0.56
47
280
(3002179) Metamyelocytes/100 leukocytes in Blood
320
2543
1.28
4.16
4.5
4.3
%
0.6
0.6
0.03
89
589
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
154
1096
1.42
4.16
1.7
1.6
iu/ml
5.8
0.2
0.46
21
225
(3028192) IgG subclass 2 [Mass/volume] in Serum
67
396
1.70
4.14
1.6
1.3
g/l
2.9
2.9
0.05
47
281
(3023487) Leukocytes [#/volume] in Peritoneal fluid
31
141
2.21
4.11
2.7
2.4
e6/l
21000.6
871.9
0.47
26
103
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
28
122
2.30
4.10
2.8
2.2
e6/l
1790.0
2701.3
0.57
23
68
(3025159) Blasts/100 leukocytes in Blood
312
2477
1.28
4.09
4.6
4.6
%
0.0
0.3
1.08
94
620
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
131
908
1.46
4.08
1.3
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
8
10
8.01
4.06
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
113
766
1.49
3.95
2.1
2.3
u/l
6094.5
3929.4
0.28
45
281
(3009871) Measles virus Ab [Titer] in Serum
30
137
2.20
3.95
1.4
1.7
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
41
212
1.94
3.91
1.1
1.2
ratio
1.0
1.0
—
10
77
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
57
328
1.75
3.89
1.2
1.2
u/l
141.1
66.6
0.45
41
224
(4062490)
66
397
1.67
3.85
1.6
1.3
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
53
300
1.78
3.83
2.8
3.2
e6/l
332.2
540.4
3.46
43
251
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
20
77
2.61
3.80
1.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
53
301
1.77
3.79
2.0
2.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
50
280
1.80
3.75
1.2
1.1
—
—
—
0
0
(4094501)
149
1076
1.40
3.74
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
94
623
1.52
3.68
4.1
3.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
161
1182
1.38
3.67
2.5
2.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
95
634
1.51
3.61
1.7
1.6
g/l
0.9
0.8
0.18
67
495
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
113
782
1.46
3.59
1.8
2.3
g/l
0.0
0.0
0.00
103
730
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
34
170
2.01
3.58
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
522
4449
1.20
3.57
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
51
857
0.59
3.53
1.2
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
92
613
1.51
3.53
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
441
3714
1.21
3.42
1.3
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
111
774
1.45
3.41
1.8
2.3
g/l
0.0
0.0
0.00
103
729
(3033799) Differential panel - Peritoneal fluid
27
126
2.15
3.41
2.8
2.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3125
30225
1.15
3.39
29.7
16.5
g/l
332.6
334.1
18.31
3108
30038
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
33
167
1.98
3.38
1.4
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
30
147
2.05
3.35
3.5
2.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
65
405
1.61
3.35
2.4
2.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
32
161
2.00
3.33
1.0
1.1
iu/ml
206.3
186.3
0.17
32
161
(3019977) pH of Arterial blood
33
169
1.96
3.28
3.5
2.8
ph
7.4
7.4
0.00
11
62
(3047189) Immunofixation for 24 hour Urine
29
142
2.05
3.25
1.3
2.0
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
84
560
1.51
3.24
5.4
3.1
mmol/l
7.4
7.4
0.01
84
543
(3045424) Erythrocytes [Presence] in Urine
83
552
1.51
3.24
1.5
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
119
851
1.41
3.21
1.8
2.2
g/l
36.5
38.0
1.69
106
760
(3045414) Leukocytes [Presence] in Urine
183
1405
1.32
3.15
1.8
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
137
1007
1.37
3.15
1.8
2.4
g/l
11.2
10.3
1.19
117
877
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
75
492
1.53
3.13
1.3
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
1037
1.36
3.07
1.8
2.3
g/l
3.3
3.0
2.12
113
830
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
117
843
1.40
3.04
1.8
2.2
g/l
0.0
0.0
0.18
107
789
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
146
1092
1.35
3.02
1.7
2.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
146
1092
1.35
3.02
1.7
2.3
g/l
7.1
7.3
0.61
117
852
(21494815) CD4 cells/100 lymphocytes in Specimen
61
385
1.59
3.02
2.3
2.9
%
31.0
41.0
—
8
41
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
74
489
1.52
3.00
1.7
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
45
264
1.71
2.95
2.3
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
47
281
1.68
2.89
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2515
24099
1.12
2.86
3.9
3.3
u/l
60.8
51.0
4.34
2387
22822
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
128
948
1.36
2.84
1.8
2.4
g/l
0.7
1.0
0.47
112
843
(4034850)
143
1078
1.34
2.83
17.8
8.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
34
186
1.83
2.82
1.7
1.7
—
—
—
0
0
(3017704) Immunofixation for Urine
31
165
1.89
2.80
1.6
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
284
2340
1.23
2.78
2.7
3.0
e9/l
4.3
4.1
0.68
224
1918
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
10
31
3.23
2.77
3.4
3.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
32
173
1.86
2.76
1.3
2.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
32
173
1.86
2.76
1.3
2.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
90
631
1.44
2.75
1.1
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
144
1092
1.33
2.75
1.8
2.3
g/l
4.1
3.9
1.14
111
811
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
36
203
1.78
2.72
1.4
1.5
u/l
20.7
5.3
0.87
16
102
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
62
404
1.54
2.71
1.3
1.3
u/l
28.7
26.2
0.25
51
330
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
15
60
2.51
2.70
1.1
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
92
652
1.42
2.67
1.3
1.2
u/ml
29.6
47.6
—
10
56
(40757494) Bilirubin.total [Moles/volume] in Blood
34
190
1.80
2.66
1.7
3.4
umol/l
15.2
73.2
—
6
22
(3035637) Corticotropin [Mass/volume] in Plasma
73
496
1.48
2.64
1.4
1.6
—
—
—
0
0
(4024509)
39
229
1.71
2.59
1.6
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
62
409
1.52
2.58
1.3
1.3
nmol/l
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
8
20
4.00
2.56
6.4
5.6
umol/l
444.8
467.5
—
8
20
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
82
575
1.43
2.53
1.3
1.3
u/l
27.3
43.6
0.95
70
498
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
61
403
1.52
2.53
1.1
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
13
50
2.60
2.53
8.4
9.0
mmol/l
5.2
6.8
1.53
13
50
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
186
1480
1.27
2.51
2.3
2.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2394
22962
1.10
2.49
3.0
2.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
58
383
1.52
2.42
1.3
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
120
905
1.34
2.42
1.7
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
63
424
1.49
2.41
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
618
5511
1.14
2.41
1.3
1.3
iu/ml
26.5
31.5
0.58
182
1712
(3026389) Candida sp identified in Specimen by Organism specific culture
57
376
1.52
2.40
1.2
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
24
124
1.94
2.40
2.8
2.5
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
7
17
4.12
2.36
8.1
9.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
12
46
2.61
2.35
1.3
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
43
267
1.62
2.34
1.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
19
91
2.09
2.32
5.0
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
19
91
2.09
2.32
5.0
2.6
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
56
371
1.52
2.32
1.4
1.4
promille
1.2
1.5
0.75
38
289
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
43
268
1.61
2.31
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
21
105
2.01
2.30
1.2
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
23
119
1.94
2.30
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
107
801
1.34
2.28
2.1
1.7
e6/l
26613.3
12630.6
0.60
79
587
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
48
309
1.56
2.27
1.2
1.3
titre
246.7
170.5
—
9
60
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
8
23
3.48
2.27
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
148
1869
0.78
2.24
1.5
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
164
1306
1.27
2.23
1.2
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
797
8727
0.89
2.23
2.5
2.7
ug/l
0.7
0.7
0.11
512
5303
(3041096) Erythrocytes [Presence] in Urine by Automated
930
8543
1.12
2.23
3.8
2.9
—
—
—
0
0
(3016750) Collection duration of Urine
36
217
1.66
2.21
2.6
2.2
min
516.6
492.1
0.77
31
162
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
10
36
2.78
2.20
1.2
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
49
320
1.54
2.18
1.8
1.4
e6/l
141668.2
69871.7
0.35
35
224
(40768793) Breast Pathology biopsy report
27
465
0.58
2.18
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
90
661
1.37
2.18
1.1
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
27
151
1.79
2.15
1.6
1.7
nmol/l
3.3
7.7
0.75
22
128
(3011335) Digoxin [Mass/volume] in Serum or Plasma
7
19
3.69
2.15
1.9
3.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
29
166
1.75
2.14
1.0
1.1
miu/ml
1418.6
1482.2
0.13
29
166
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
30
3.00
2.14
1.6
2.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
90
664
1.36
2.13
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
25
137
1.83
2.13
1.4
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
25
137
1.83
2.13
1.4
1.5
—
—
—
0
0
(3036603) Volume of Urine
35
212
1.66
2.12
1.6
1.7
ml
1583.5
2022.9
—
6
39
(3048689) Calprotectin [Mass/mass] in Stool
463
4092
1.15
2.07
2.5
2.6
ug/g
134.3
139.3
0.12
374
3321
(3013166) Neutrophils/100 leukocytes in Synovial fluid
21
110
1.91
2.05
2.0
1.4
%
57.7
52.4
0.25
16
99
(3044007) Cell count panel - Peritoneal fluid
21
110
1.91
2.05
3.4
2.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
37
230
1.61
2.04
1.1
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
32
192
1.67
2.02
2.5
2.4
umol/l
51.2
55.3
0.29
23
167
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
56
386
1.46
1.96
1.6
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
20
362
0.55
1.96
3.9
3.5
u/ml
21.9
26.4
0.27
20
352
(4146454)
50
338
1.49
1.93
2.8
2.6
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
16
3.75
1.93
1.0
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
54
371
1.46
1.93
1.7
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
33
2.73
1.93
1.6
2.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
25
142
1.77
1.92
1.5
2.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
15
71
2.12
1.92
1.2
2.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
29
173
1.68
1.89
1.3
1.4
u/ml
24.4
23.1
—
7
34
(3025468) Yersinia sp identified in Specimen by Organism specific culture
54
373
1.45
1.88
1.6
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
54
373
1.45
1.88
1.6
1.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
7
22
3.19
1.88
9.0
4.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3284
32173
1.11
1.87
25.8
14.1
%
39.4
40.9
19.34
2446
24917
(3005988) Vibrio sp identified in Specimen by Organism specific culture
54
374
1.45
1.86
1.6
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
198
1647
1.21
1.86
1.5
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
23
129
1.79
1.85
1.2
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
455
0.61
1.85
1.3
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
46
309
1.49
1.85
2.2
1.5
%
19.2
31.2
2.21
34
192
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
124
982
1.27
1.82
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
122
965
1.27
1.81
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
73
537
1.37
1.81
1.9
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
20
351
0.57
1.78
1.4
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
105
817
1.29
1.78
1.5
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
47
2.34
1.77
2.6
2.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
81
608
1.34
1.77
1.9
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
293
2540
1.17
1.74
1.9
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
54
380
1.43
1.73
1.6
1.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
193
0.47
1.72
1.2
2.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
54
381
1.42
1.71
1.6
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
27
163
1.66
1.71
1.2
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
424
3781
1.14
1.69
5.1
4.3
%
31.1
31.0
0.02
338
2678
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
61
441
1.39
1.69
1.0
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
31
480
0.64
1.69
1.0
1.1
u/ml
0.2
0.5
—
9
142
(3008757) Leukocyte morphology finding [Identifier] in Blood
53
374
1.42
1.68
3.1
4.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
28
172
1.63
1.66
1.5
2.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
28
172
1.63
1.66
1.2
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
28
172
1.63
1.66
1.5
2.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
28
172
1.63
1.66
1.5
2.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
20
343
0.58
1.66
1.3
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
29
180
1.62
1.66
1.6
1.7
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
18
97
1.86
1.65
1.2
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
18
97
1.86
1.65
1.2
1.1
%
92.4
87.6
0.27
18
97
(3036525) Urea [Moles/time] in 24 hour Urine
7
25
2.80
1.65
1.9
3.6
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
25
2.80
1.65
1.0
1.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
483
5347
0.89
1.64
1.9
1.9
%
1.6
1.5
2.19
433
4783
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
76
1.98
1.64
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
20
341
0.58
1.63
1.3
1.4
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
5
14
3.57
1.61
1.6
4.1
mmol/l
4.3
4.5
—
5
14
(3000060) B lymphocytes [#/volume] in Blood
26
159
1.64
1.58
2.1
3.2
e6/l
241.4
256.2
0.12
14
98
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
47
329
1.43
1.58
2.7
2.9
e6/l
457.7
674.5
1.97
20
112
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
87
673
1.30
1.57
1.5
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
207
1.55
1.56
1.5
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
20
114
1.76
1.56
3.5
3.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
48
339
1.42
1.54
1.3
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
70
527
1.33
1.54
2.8
3.8
%
0.9
1.5
1.77
60
410
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
44
306
1.44
1.53
1.7
1.5
g/l
1.0
1.0
0.03
44
306
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
23
138
1.67
1.51
1.1
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
17
93
1.83
1.51
2.6
1.8
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
21
2.86
1.50
1.8
1.3
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
6
21
2.86
1.50
1.0
1.1
—
—
—
0
0
(3001729) Color of Synovial fluid
6
21
2.86
1.50
2.8
1.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
35
234
1.50
1.49
1.4
1.4
ug/l
8.6
5.0
0.44
26
201
(3039443) Prostate specific Ag panel - Serum or Plasma
96
1204
0.79
1.47
1.5
1.6
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
8
168
0.48
1.46
2.8
2.3
nmol/l
160.9
154.2
—
8
148
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
35
236
1.49
1.44
1.2
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
27
172
1.57
1.42
1.6
2.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
162
1364
1.20
1.41
3.9
2.9
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
28
181
1.55
1.39
1.6
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
257
2250
1.15
1.39
1.3
1.3
u/ml
196.7
235.6
0.52
239
2089
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
110
1348
0.81
1.39
2.2
1.7
mg/l
3.5
4.2
0.56
85
957
(3004775) Volume in Urine collected for unspecified duration
40
280
1.43
1.37
2.5
2.3
ml
752.3
632.8
0.91
32
195
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
39
273
1.43
1.34
1.3
1.3
mmol/l
10.8
11.9
—
9
91
(3034891) Synovial lining cells/100 cells in Synovial fluid
25
159
1.58
1.34
2.3
1.4
%
2.5
4.3
0.45
11
34
(3013139) Helicobacter pylori Ag [Presence] in Stool
232
2025
1.15
1.32
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
26
168
1.55
1.31
1.2
1.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
43
2.10
1.30
1.0
1.0
—
—
—
0
0
(44813793)
34
234
1.46
1.29
1.1
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1320
12592
1.07
1.29
2.0
2.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
28
185
1.52
1.28
2.3
2.2
umol/l
1.8
1.9
0.57
28
175
(3003327) Ova and parasites identified in Stool by Light microscopy
138
1158
1.20
1.27
1.8
1.7
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
15
84
1.79
1.27
1.1
1.6
%
29.7
27.1
0.14
15
78
(3001964) Herpes simplex virus Ag [Presence] in Specimen
18
107
1.69
1.25
1.8
1.8
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
14
77
1.82
1.25
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
66
511
1.30
1.24
1.9
1.8
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
45
2.00
1.23
1.9
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
364
4020
0.90
1.23
2.3
2.3
nmol/l
12.7
13.6
1.79
325
3604
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
10
49
2.04
1.22
1.1
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
15
252
0.59
1.21
1.0
1.0
ng/l
43.4
44.0
—
10
177
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
15
252
0.59
1.21
1.0
1.0
ng/l
303.7
310.7
—
10
183
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
29
419
0.69
1.20
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
29
418
0.69
1.18
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
29
418
0.69
1.18
1.3
1.4
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
15
250
0.60
1.18
1.0
1.0
ng/l
922.1
762.3
—
9
177
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
109
1.65
1.18
1.7
2.2
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
29
417
0.69
1.17
1.3
1.4
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
39
2.05
1.15
1.5
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
20
126
1.59
1.14
2.1
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
53
405
1.31
1.12
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
45
336
1.34
1.11
1.6
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
20
127
1.58
1.11
2.8
2.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
31
217
1.43
1.11
3.5
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
665
6224
1.08
1.09
1.6
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
34
467
0.73
1.07
1.2
1.4
pmol/l
83.1
129.8
0.32
17
147
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
11
192
0.57
1.05
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
33
2.12
1.05
1.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
33
2.12
1.05
3.1
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
14
82
1.71
1.05
1.4
1.8
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
46
1.96
1.03
1.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
34
2.06
1.02
2.1
5.7
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
34
2.06
1.02
3.3
6.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
20
130
1.54
1.02
1.7
2.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
20
130
1.54
1.02
1.7
2.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
20
130
1.54
1.02
1.8
2.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
34
247
1.38
1.01
2.3
2.7
%
38.2
38.2
0.00
12
74
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
32
230
1.39
1.01
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
30
413
0.72
0.98
2.1
2.6
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
30
0.00
0.97
0.0
2.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
36
267
1.35
0.96
1.7
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
32
233
1.38
0.95
1.4
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
9
51
1.77
0.94
1.1
1.2
—
6.1
—
0
9
(3017509) Phencyclidine [Presence] in Urine
7
37
1.89
0.94
1.3
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
43
556
0.77
0.93
1.0
1.1
u/ml
2.0
4.8
1.43
16
248
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
27
2.22
0.93
1.2
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
51
400
1.28
0.93
1.9
1.6
%
71.5
58.5
1.91
38
247
(3044242) Glucose [Moles/volume] in Arterial blood
22
150
1.47
0.92
2.0
2.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
21
142
1.48
0.92
1.0
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
47
367
1.28
0.89
1.5
1.4
mosm/kgh2o
278.8
282.5
0.38
41
285
(3025130) Human papilloma virus identified in Specimen
38
288
1.32
0.89
1.7
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
81
969
0.83
0.89
3.2
3.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
87
729
1.20
0.89
2.1
1.9
iu/l
3.6
4.9
1.19
38
268
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
23
160
1.44
0.88
3.7
3.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
15
95
1.58
0.87
1.5
1.5
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
44
343
1.29
0.85
2.7
1.4
iu/ml
32.3
26.2
—
7
14
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
78
650
1.20
0.85
3.6
3.9
u/ml
690.3
735.0
0.03
72
607
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
26
187
1.39
0.85
2.4
2.1
umol/l
27.3
28.2
0.22
26
180
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1142
11864
0.95
0.83
3.6
3.7
%
22.7
21.4
1.64
496
5164
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
365
0.74
0.82
1.0
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
6
32
1.88
0.81
1.7
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
32
1.88
0.81
1.2
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
42
330
1.28
0.78
2.0
2.1
mg/l
16.4
21.6
0.52
12
91
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
74
1.62
0.78
2.2
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
207
1870
1.11
0.78
3.1
2.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
552
5205
1.07
0.78
1.3
1.2
u/ml
6.8
11.8
1.60
224
2104
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
11
174
0.63
0.76
1.3
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
102
881
1.16
0.76
1.1
1.1
u/ml
3.6
6.0
0.51
13
137
(3051387) C reactive protein [Mass/volume] in Capillary blood
72
604
1.20
0.75
4.0
3.4
mg/l
21.7
24.8
0.40
53
367
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
52
422
1.24
0.75
1.3
1.5
nmol/l
0.7
0.3
0.85
34
320
(3000034) Microalbumin [Mass/volume] in Urine
42
333
1.26
0.74
2.4
2.8
mg/l
66.8
55.6
0.09
33
247
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
33
254
1.30
0.73
1.2
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
56
1.61
0.72
1.3
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
10
60
1.67
0.72
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
33
423
0.78
0.72
1.9
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
77
654
1.18
0.71
1.5
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
40
319
1.26
0.69
2.5
3.9
%
62.2
56.9
0.74
31
204
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
32
248
1.29
0.68
1.5
1.6
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
5
27
1.85
0.68
1.2
1.2
—
—
—
0
0
(3025315) Body weight
5
27
1.85
0.68
8.0
2.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
33
258
1.28
0.66
1.2
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
28
1.79
0.66
1.2
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
7
44
1.59
0.65
4.0
10.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
189
0.69
0.63
1.0
1.0
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
41
332
1.24
0.63
1.1
1.1
mg/l
319.6
278.7
1.85
34
306
(3036670) Protein [Mass/volume] in Synovial fluid
13
87
1.50
0.63
1.2
1.2
g/l
42.3
39.0
—
8
48
(3044290) Cell count panel - Cerebral spinal fluid
66
773
0.85
0.63
1.7
2.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
29
225
1.29
0.63
1.2
1.6
u/l
5.7
7.2
0.89
23
192
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
110
973
1.13
0.62
1.3
1.3
miu/ml
204.9
207.6
0.02
45
417
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
31
243
1.28
0.62
2.3
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
97
851
1.14
0.62
2.7
2.4
ug/min
127.2
122.5
0.05
62
549
(3049233) Organic acids panel - Urine
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.4
—
27.5
—
0
21
(40759836) Histone Ab [Presence] in Serum by Immunoblot
32
254
1.26
0.59
1.2
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
53
1.51
0.58
1.5
2.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
8
53
1.51
0.58
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
32
255
1.26
0.58
1.2
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
36
1.67
0.56
1.0
1.0
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
35
283
1.24
0.56
2.9
2.7
umol/l
6.6
9.4
0.85
27
209
(3035933) Granulocytes/100 leukocytes in Blood
10
149
0.67
0.56
1.1
1.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
115
1.39
0.56
1.1
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
73
1.51
0.56
1.4
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
43
516
0.83
0.56
1.0
1.1
u/ml
1.6
5.7
3.66
21
228
(3038177) Helicobacter pylori Ab [Presence] in Serum
48
570
0.84
0.55
1.2
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
17
229
0.74
0.55
16.5
12.0
mmol/l
0.6
0.6
0.01
17
211
(3041672) Baker's yeast Ab [Presence] in Serum
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
15
107
1.40
0.55
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
52
612
0.85
0.55
4.8
5.5
umol/l
366.3
371.5
0.11
46
548
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
18
133
1.35
0.55
1.6
1.6
mmol/l
5.7
8.1
—
7
82
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
67
580
1.16
0.54
1.1
1.1
au/ml
10.2
10.3
—
6
38
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
32
258
1.24
0.53
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
32
258
1.24
0.53
1.2
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
61
1.48
0.53
1.9
1.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
15
108
1.39
0.53
1.1
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
18
134
1.34
0.53
1.2
1.2
u/ml
0.2
25.4
—
8
86
(21494434) Karyotype in Bone marrow
36
295
1.22
0.52
1.2
1.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
10
66
1.52
0.52
1.2
2.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
9
63
1.43
0.52
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
17
226
0.75
0.52
1.2
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
6
97
0.62
0.52
1.0
1.1
—
4.7
—
0
13
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
36
296
1.22
0.51
3.4
4.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
30
243
1.24
0.49
1.5
1.9
mmol/l
6.1
6.8
1.39
21
163
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
190
0.74
0.49
1.2
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
64
732
0.87
0.48
1.0
1.1
u/ml
0.4
1.3
2.30
32
370
(4133840)
16
119
1.35
0.48
1.3
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
66
752
0.88
0.48
1.0
1.1
u/ml
5.5
5.1
0.08
33
435
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
29
235
1.24
0.48
1.1
1.2
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
102
1.37
0.47
1.1
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
12
85
1.41
0.46
2.1
2.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
127
1389
0.91
0.46
2.3
2.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
217
2028
1.07
0.46
1.2
1.2
iu/ml
120.0
148.3
0.50
81
749
(40765096) Chromosome analysis panel by Banding
8
118
0.68
0.45
1.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
83
0.60
0.45
1.2
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
26
211
1.23
0.43
1.7
2.1
u/field
1.0
1.6
—
10
106
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
9
127
0.71
0.43
1.0
1.1
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
9
129
0.70
0.43
1.0
1.0
mmol/l
19.9
19.9
—
9
115
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
91
0.66
0.42
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
32
1.56
0.42
3.6
2.6
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
5
32
1.56
0.42
1.0
1.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
8
58
1.38
0.41
2.1
4.4
umol/l
36.1
44.8
—
8
46
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
15
0.00
0.41
0.0
1.1
—
8.1
—
0
15
(3032641) Amino acids panel - Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
76
847
0.90
0.41
1.7
2.0
e6/l
3255.5
1239.9
0.52
64
671
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
59
1.36
0.41
1.0
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
106
1160
0.91
0.40
1.8
1.6
mu/l
330.6
293.7
0.64
94
1080
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
309
2937
1.06
0.40
3.7
4.5
ug/l
37.0
20.0
0.28
241
2404
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
76
846
0.90
0.40
1.6
1.9
e6/l
16.6
22.1
0.18
62
633
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
60
1.33
0.40
1.0
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
168
1.25
0.40
2.8
2.7
umol/l
310.9
167.2
—
9
90
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
7
101
0.69
0.39
1.1
2.5
mmol/l
1.8
1.9
—
7
75
(3010937) Rubella virus Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
11
80
1.38
0.38
1.9
2.3
umol/l
15.1
18.8
0.95
11
80
(3010726) Horse dander IgE Ab [Units/volume] in Serum
63
706
0.89
0.38
1.0
1.1
u/ml
1.5
2.8
0.60
12
192
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
36
1.39
0.38
1.0
1.3
umol/24h
1.6
1.8
—
5
36
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
36
1.39
0.38
7.2
2.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
138
1485
0.93
0.37
2.2
2.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
98
1.33
0.37
1.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
14
107
1.31
0.37
1.2
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
58
515
1.13
0.37
1.7
1.8
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
70
1.29
0.36
1.2
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
70
1.29
0.36
1.2
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1459
14839
0.97
0.35
3.9
4.2
ug/l
1.8
2.2
2.95
1320
13566
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
120
1111
1.08
0.35
3.6
4.0
u/ml
343.3
2326.8
1.12
103
957
(3029396) Erythrocyte agglutination [Presence] in Blood
6
43
1.40
0.35
3.5
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
9
125
0.72
0.35
9.6
5.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
107
1159
0.92
0.35
2.4
2.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
9
126
0.71
0.35
4.8
2.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
73
1.37
0.34
1.2
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
140
1499
0.93
0.34
2.5
2.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
30
255
1.18
0.34
1.3
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
41
358
1.15
0.34
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
82
1.34
0.34
1.4
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
82
1.34
0.34
1.4
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
82
1.34
0.34
1.4
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
82
1.34
0.34
1.4
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
17
136
1.25
0.33
1.1
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
109
1.29
0.33
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
137
1464
0.93
0.32
2.2
2.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
24
201
1.20
0.32
1.1
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
140
1494
0.93
0.32
2.1
2.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
135
1263
1.07
0.31
2.6
2.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
20
165
1.21
0.31
3.0
4.6
mg/l
6.2
8.0
1.11
15
139
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
16
197
0.81
0.31
1.1
1.1
u/l
1.2
1.1
—
6
100
(44816559) Phosphatidylethanol [Mass/volume] in Blood
86
791
1.09
0.31
1.5
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
212
1.18
0.30
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
280
2683
1.05
0.30
1.1
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
10
130
0.77
0.29
1.0
1.0
mu/l
7.7
9.2
—
10
121
(3021706) Oxygen [Partial pressure] in Arterial cord blood
8
109
0.73
0.29
1.0
1.0
kpa
3.0
3.2
—
8
99
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
8
110
0.73
0.28
1.0
1.0
kpa
6.5
7.2
—
8
100
(3006598) pH of Arterial cord blood
8
110
0.73
0.28
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
186
1.18
0.27
5.9
6.7
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
17
140
1.22
0.27
3.1
2.9
umol/l
33.4
29.7
0.78
12
99
(3020874) Milk IgE Ab [Units/volume] in Serum
22
258
0.85
0.27
1.1
1.2
u/ml
0.6
2.7
—
10
113
(3009214) Lutropin [Units/volume] in Serum or Plasma
132
1244
1.06
0.27
1.7
1.5
u/l
9.5
7.2
1.05
98
981
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
11
86
1.28
0.26
1.2
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
10
77
1.30
0.26
3.3
2.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
22
256
0.86
0.25
1.2
1.2
u/ml
8.3
4.0
—
7
99
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
15
123
1.22
0.25
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
14
114
1.23
0.25
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
145
1375
1.06
0.25
1.5
1.5
iu/l
27.7
27.1
0.07
121
1128
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
74
797
0.93
0.24
1.4
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
336
3469
0.97
0.24
1.5
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
38
1.32
0.23
1.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
82
766
1.07
0.23
1.6
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
16
134
1.19
0.22
1.4
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
28
316
0.89
0.22
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
175
1826
0.96
0.22
1.0
1.1
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
10
0.00
0.21
0.0
2.3
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
2.5
—
0
12
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
61
657
0.93
0.21
1.2
1.1
iu/ml
168.4
924.3
0.44
12
153
(4015189)
10
80
1.25
0.20
3.0
2.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
123
0.81
0.20
1.2
1.2
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.0
—
0
5
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
0.1
—
0
5
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
41
374
1.10
0.20
1.3
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
361
3706
0.97
0.20
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
22
250
0.88
0.20
1.1
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
24
271
0.88
0.20
1.0
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
227
2193
1.04
0.20
1.2
1.3
au/ml
91.9
49.3
0.84
12
107
(3006462) Nitrate [Presence] in Urine
15
127
1.18
0.19
2.3
2.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
31
279
1.11
0.19
1.3
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
32
290
1.10
0.18
4.5
4.9
u/ml
20.9
51.9
—
10
84
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
33
300
1.10
0.17
1.3
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
68
0.73
0.17
2.4
1.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
8
70
1.14
0.16
1.3
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
16
183
0.87
0.16
1.1
1.6
umol/l
23.1
23.1
0.00
16
175
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
72
1.11
0.16
2.1
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
246
2394
1.03
0.15
2.3
2.3
au/ml
25.7
21.8
—
10
139
(3027923) C peptide [Moles/volume] in Serum or Plasma
23
207
1.11
0.15
1.5
1.4
nmol/l
1.1
1.2
0.10
17
159
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
72
758
0.95
0.14
1.2
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
87
0.80
0.14
1.3
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
7
89
0.79
0.14
1.9
1.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
21
233
0.90
0.14
6.1
7.4
u/ml
827.8
613.5
—
5
60
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
139
0.86
0.14
3.7
4.0
—
—
—
0
0
(4211845)
16
141
1.14
0.13
2.3
2.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
63
664
0.95
0.13
2.2
3.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
100
0.80
0.13
1.1
1.5
—
—
—
0
0
(4035726)
285
2788
1.02
0.13
1.7
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
17
151
1.13
0.13
1.1
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
31
335
0.92
0.13
1.4
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
80
835
0.96
0.12
1.1
1.2
u/ml
0.3
2.3
4.78
38
403
(4198724)
22
200
1.10
0.12
1.8
2.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
11
95
1.16
0.11
1.6
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
17
153
1.11
0.11
1.1
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
359
3647
0.98
0.10
1.5
1.6
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
5
44
1.14
0.10
1.0
1.2
—
32.6
—
0
15
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
5
44
1.14
0.10
1.0
1.2
—
23.2
—
0
10
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
44
1.14
0.10
1.2
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
12
106
1.13
0.09
2.9
2.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
35
330
1.06
0.09
1.9
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
123
1198
1.03
0.09
1.6
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
11
124
0.89
0.09
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
17
155
1.10
0.09
1.8
2.5
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
55
1.09
0.08
1.2
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
56
1.07
0.08
2.3
3.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
57
1.05
0.08
1.7
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
35
369
0.95
0.08
1.5
1.6
—
—
—
0
0
(44806420)
5
65
0.77
0.08
2.4
2.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
26
244
1.07
0.08
1.3
1.3
u/ml
2.9
0.7
0.34
13
107
(3047007) Chlamydophila sp Ab [Presence] in Serum
56
539
1.04
0.08
1.2
1.2
—
—
—
0
0
(4027681)
22
235
0.94
0.07
1.2
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
315
3111
1.01
0.07
1.9
1.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
18
194
0.93
0.07
1.2
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
141
1382
1.02
0.07
2.2
1.8
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
84
1.07
0.07
1.2
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
19
204
0.93
0.07
1.3
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
16
173
0.92
0.06
1.5
2.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
105
0.86
0.06
1.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
86
840
1.02
0.06
3.0
1.9
nmol/l
1.0
0.8
1.27
77
710
(3008898) HLA-B27 [Presence]
126
1237
1.02
0.06
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
208
1.06
0.05
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
110
1.09
0.05
1.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
46
474
0.97
0.04
1.2
1.2
mmol/l
7.3
7.4
0.08
35
351
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
27
281
0.96
0.04
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
28
291
0.96
0.04
1.0
1.2
mg/l
28.5
45.5
3.68
22
236
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
40
412
0.97
0.04
1.2
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
56
548
1.02
0.03
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
18
189
0.95
0.03
1.3
1.3
nmol/l
153.8
139.8
0.58
18
189
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
173
1714
1.01
0.03
1.0
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
108
1092
0.99
0.02
2.3
3.3
u/ml
67.5
53.8
0.24
103
1051
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
341
3426
0.99
0.02
2.0
2.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
52
513
1.01
0.01
1.0
1.1
u/ml
2.0
3.0
0.80
20
252
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
126
0.95
0.00
1.0
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
16
154
1.04
0.00
2.4
2.6
mmol/l
8.6
9.5
0.41
11
116
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
17
166
1.02
0.00
2.1
2.0
ug/min
20.8
311.3
—
6
40
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
150
1.00
0.00
1.1
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
13
130
1.00
0.00
2.2
2.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
159
1591
1.00
0.00
2.7
2.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
39
391
1.00
0.00
1.2
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
23
227
1.01
0.00
1.2
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
105
1.05
0.00
1.4
1.4
ug/l
11.0
8.8
0.51
11
105
(4281824)
28
275
1.02
0.00
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
66
663
1.00
0.00
2.5
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
51
508
1.00
0.00
1.4
1.4
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
12
121
0.99
0.00
1.3
1.2
g/l
0.3
0.3
—
6
102
(3048879) Bone marrow aspiration report
7
79
0.89
0.00
2.7
2.4
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
7.9
—
0.3
—
0
8
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
7.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
50
1.00
0.00
1.2
1.2
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
52
0.96
0.00
1.0
1.0
g/l
170.0
162.9
—
5
52
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005067) clonazePAM [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
35.0
—
0
5
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
92
0.98
0.00
1.1
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
2.2
—
0
9
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
0.4
—
0
5
(40760512) CD34 cells/100 cells in Bone marrow
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
1310.0
—
0
6
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
68
0.88
0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_LVOTO_BROAD and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_LVOTO_BROAD | 2.816 [2.48, 3.2] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.113 |
During the follow-up period (1.1.1998 — 31.12.2019), 723 out of 7117 females with Q17_LVOTO_BROAD died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_LVOTO_BROAD | 2.127 [1.95, 2.32] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 2108 out of 13572 males with Q17_LVOTO_BROAD died.
Mortality risk
Mortality risk for people of age
years, who have Q17_LVOTO_BROAD.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.296% | 0.383% |
| 5 | 1.631% | 2.28% |
| 10 | 3.766% | 5.878% |
| 15 | 6.847% | 11.198% |
| 20 | 12.257% | 18.872% |
Relationships between endpoints
↥Index endpoint: Q17_LVOTO_BROAD – Left ventricular outflow tract obstruction (LVOTO), broad definition
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data